PERSONAL DETAIL


DATO' PROF. DR. ADEEBA BINTI KAMARULZAMAN

Profesor
Jabatan Perubatan
Fakulti Perubatan
 
  +603-79492050
  adeeba@um.edu.my
 Jabatan Perubatan, Fakulti Perubatan, University of Malaya, 50603 Kuala Lumpur, W.Persekutuan Kuala Lumpur, Malaysia
 
Homepage
 
ResearcherID Link
  http://www.researcherid.com/rid/B-5216-2010

BIOGRAPHY


Professor Adeeba Kamarulzaman graduated from Monash University in 1987 and trained in internal medicine and infectious diseases at the Monash Medical Centre and Fairfield Infectious Diseases Hospital, Melbourne, Australia. She is presently the Dean of the Faculty of Medicine, University of Malaya and an Adjunct Associate Professor at Yale University, USA. She established the Centre of Excellence for Research on AIDS (CERiA) that conducts multi-disciplinary research on HIV ranging from clinical to public health and policy research.

Professor Kamarulzaman has used her clinical and academic leadership to engage in the national and community response to HIV/AIDS. She is currently Chairman of the Malaysian AIDS Foundation and an Executive Council member of the Malaysian AIDS Council, the peak HIV NGO in Malaysia.

At the international level, Professor Kamarulzaman is presently an Executive Council Member of the International AIDS Society and a member of the UNAIDS Scientific Expert Panel on HIV. She has also been an advisor to numerous WHO committees on HIV/AIDS. She has played a key role in the establishment and ongoing activities and collaborations of a regional HIV research network initiative; TREAT Asia.

Her achievements have been recognised through several national and international awards including the Tun Mahathir Science and the Merdeka Awards for her role as a member of the University of Malaya’s Nipah Investigative Team. She is the first recipient of the Advance Australia Global Award in the category of Alumni in 2012 and in April 2015 she was honoured with a Doctor of Laws (honoris causa) from her alma mater, Monash University. She also has the distinct honour of having been featured in both The Lancet and Science publications in 2013 and 2014 respectively.

 


ACADEMIC QUALIFICATION
(Qualification), (Institution).



PROFESSIONAL
(Organisation), (Role), (Year), (Level).


  • Malaysian Medical Association , Active Member, 2014, (National)
  • Academy of Medicine, Academic Committee Member, 2015, (National)
  • Academy of Science Malaysia , Active Member, 2016, (National)
  • Majlis Perubatan Malaysia, Panel Member, 2017 to 2017, (National)
  • World Health Organization, Expert Panel Member, 2017 to 2021, (International)
  • Academy of Medicine Malaysia, Chairperson Of The Amm Education And Training Committee, 2017 to 2018, (National)
  • Merdeka Award Secretariat, Committee, 2018 to 2020, (National)
  • Ahli Jawatankuasa Pengajian Program Doktor Perubatan, Fakulti Perubatan dan Sains Kesihatan, Committee Member, 2018 to 2021, (National)
  • International AIDS Society , 1st Vice President, 2018 to 2020, (International)

ADMINISTRATIVE DUTIES
(Role), (Level), (Start date),(End Date).


  • Head of Unit, Centre of Excellence for Research in Aids (Ceria), Faculty of Medicine, 01/01/2020 to 31/12/2021
  • Dean, Dean's Office, Faculty of Medicine, 03/12/2018 to 02/12/2020
  • AHLI MAJLIS PENASIHAT KESIHATAN, University Malaya, 09/11/2018 to 08/11/2020
  • Dean, Dean's Office, Faculty of Medicine, 11/10/2018 to 02/12/2018
  • Exercising The Function of Dean, Dean's Office, Faculty of Medicine, 01/07/2018 to 10/10/2018
  • Head of Unit, Centre of Excellence for Research in Aids (Ceria), Faculty of Medicine, 01/01/2018 to 31/12/2019
  • Dean, Dean's Office, Faculty of Medicine, 01/07/2016 to 30/06/2018
  • Head of Unit, Centre of Excellence for Research in Aids (Ceria), Deputy Vice Chancellor(Research & Innovation), 01/01/2016 to 31/12/2017
  • Ahli Lembaga Pengurus Pusat Perubatan University Malaya, University Malaya, 20/04/2015
  • Ahli Lembaga Penasihat CIC, University Malaya, 09/02/2015
  • Head of Unit, Centre of Excellence for Research in Aids (Ceria), Deputy Vice Chancellor(Research & Innovation), 01/01/2015 to 31/12/2015
  • Dean, Dean's Office, Faculty of Medicine, 01/07/2014 to 30/06/2016
  • Head of Unit, Centre of Excellence for Research in Aids (Ceria), Deputy Vice Chancellor(Research & Innovation), 02/01/2014 to 31/12/2014
  • Dean, Dean's Office, Faculty of Medicine, 01/07/2012 to 30/06/2014
  • Dean, Dean's Office, Faculty of Medicine, 01/07/2011 to 30/06/2012
  • Senate member, University Malaya, University Malaya, 01/08/2010 to 24/01/2022
  • Chair - Infection Control Committee , UMMC, University Malaya, 01/01/2006 to 31/12/2011

AREAS OF EXPERTISE
(Area).


  • Infectious/Communicable Diseases (Specialist In Infectious Diseases NSR)
  • Infectious/Communicable Diseases


RECENT SELECTED PUBLICATIONS
(Publication).


Book

2009
  • Is It HIV ? A handbook for healthcare providers. Australasian Soceity for HIV Medicine & Treat Sia . 2009, Editor 

2004
  • University Hospital Antibiotic Policy and Guidelines 2004 - 2006 . Editors A kamarulzaman , N Parasaktthi 
  • Rapid Situation Assessment of Malaysia 2004, G Reid, A Kamarulzaman, S Kaur . 1-41 

2000
  • Consensus Guidelines on the Management of Staphylococcus aureus infections . Editor A Kamarulzaman . April 2000 

1998
  • 1st National Consensus Guidelines on Antiretroviral Therapy. October 1998 Editors C Lee, A Kamarulzaman, M Alias, N Othman 
Chapter in Book

2016
  • Ng CW, Mohd Hairi NN, Ng CJ, Kamarulzaman A. 2016. Universal Health Coverage in Malaysia: Issues and Challenges. In Tey NP, Cheong KC, Rasiah R (eds). Revisiting Malaysia's Population-Development Nexus. The Past in Its Future. Kuala Lumpur: University of Malaya Press. 

2008
  • A Kamarulzaman, K Razali. The HIV epidemic in Malaysia. Public Health Aspects of HIV/AIDS in Developing Countries: Epidemiology, Prevention and Care. Editors C Beyrer, D Celentano Springer, New York 2008. 

2006
  • P du Cros, A Kamarulzaman. HIV and Tuberculosis Coinfection. Delivering HIV Care and Treatment for People Who Use Drugs: Lessons from Research and Practice. Editor: M Curtis. International Harm Reduction Development Program. Open Society Institute. 2006 
  • A Kamarulzaman. Sepsis. Management aspects of acute care. Eds: Chan YK, Ng KP. 2006:179-187 

2002
  • A Kamarulzaman. Common viral infections in Aisa . Principles and Practice of clinical Medicine in Asia. Treating the Asian Patient. Eds : JJY Sung, LKS Wong, PKT Li, J Sanderson, TCY Kwok. 2nd Edn : 2002 

1995
  • A Kamarulzaman, J Hoy. Cryptosporidia and microsporidia. In Fairfield Hospital HIV Handbook. Eds: F Bowden, A Mijch 1995; 43-44 
Article in Academic Journals

2019
  • Jiamsakul A, Polizzotto M, Wen-Wei Ku S, Tanuma J, Hui E, Chaiwarith R, Kiertiburanakul S, Avihingasanon A, Yunihastuti E, Kumarasamy N, Ly PS, Pujari S, Ditangco R, Do CD, Merati TP, Kantipong P, Zhang F, Van Nguyen K, Kamarulzaman A, Choi JY, Sim BLH, Ng OT, Ross J, Wong W. Brief Report: Malignancies in Adults Living With HIV in Asia. J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):301-307. doi: 10.1097/QAI.0000000000001918. PubMed PMID: 30531303; PubMed Central PMCID: PMC6375805. (ISI-Indexed)
  • Kamarulzaman A, Verster A, Altice FL. Prisons: ignore them at our peril. Curr Opin HIV AIDS. 2019 Sep;14(5):415-422. (ISI-Indexed)
  • Chandra DK, Bazazi AR, Nahaboo Solim MA, Kamarulzaman A, Altice FL, Culbert GJ. Retention in clinical trials after prison release: results from a clinical trial with incarcerated men with HIV and opioid dependence in Malaysia. HIV Res Clin Pract. 2019 Feb;20(1):12-23. (ISI-Indexed)
  • Lim SH, Alias H, Kien JKW, Akbar M, Kamarulzaman A, Wong LP. A Qualitative Study of HIV "Test-and-Treat" Experience Among Men Who Have Sex With Men in Malaysia. AIDS Educ Prev. 2019 Jun;31(3):193-205. (ISI-Indexed)
  • Lall P, Saifi R, Baggio D, Schoenberger SF, Choo M, Gilbert L, West B, El-Bassel N, Kamarulzaman A. Risk Factors for a Positive Hepatitis C Status in Fishermen in Kuantan Malaysia. Asia Pac J Public Health. 2019 Apr;31(3):227-237. (ISI-Indexed)
  • Lim SH, Alias H, Kien JKW, Akbar M, Kamarulzaman A, Wong LP. A Qualitative Study of HIV "Test-and-Treat" Experience Among Men Who Have Sex With Men in Malaysia.AIDS Educ Prev. 2019 Jun;31(3):193-205. doi: 10.1521/aeap.2019.31.3.193. (ISI-Indexed)
  • Jiamsakul A, Kiertiburanakul S, Ng OT, Chaiwarith R, Wong W, Ditangco R, Nguyen KV, Avihingsanon A, Pujari S, Do CD, Lee MP, Ly PS, Yunihastuti E, Kumarasamy N, Kamarulzaman A, Tanuma J, Zhang F, Choi JY, Kantipong P, Sim B, Ross J, Law M, Merati TP; TREAT Asia HIV Observational Database of IeDEA Asia-Pacific. Long-term loss to follow-up in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2019 Aug;20(7):439-449. (ISI-Indexed)
  • Bijker R, Kumarasamy N, Kiertiburanakul S, Pujari S, Lam W, Chaiwarith R, Wong WW, Kamarulzaman A, Kantipong P, Avihingsanon A, Nguyen KV, Tanuma J, Ng OT, Sim BL, Merati TP, Choi JY, Ditangco R, Yunihastuti E, Sun LP, Do CD, Ross J, Law M; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. Cardiovascular disease incidence projections in the TREAT Asia HIV Observational Database (TAHOD). Antivir Ther. 2019;24(4):271-279. (ISI-Indexed)
  • Ku SW, Jiamsakul A, Joshi K, Pasayan MKU, Widhani A, Chaiwarith R, Kiertiburanakul S, Avihingsanon A, Ly PS, Kumarasamy N, Do CD, Merati TP, Nguyen KV, Kamarulzaman A, Zhang F, Lee MP, Choi JY, Tanuma J, Khusuwan S, Sim BLH, Ng OT, Ratanasuwan W, Ross J, Wong WW; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV. J Int AIDS Soc. 2019 Mar;22(3):e25264. (ISI-Indexed)
  • Pasayan MKU, S Mationg ML, Boettiger D, Lam W, Zhang F, Ku SW, Merati TP, Chaiwarith R, Cuong DD, Yunihastuti E, Kiertiburanakul S, Van Kinh N, Avihingsanon A, Sun LP, Kamarulzaman A, Kantipong P, Kumarasamy N, Pujari S, Heng Sim BL, Ng OT, Choi JY, Tanuma J, Ross J, A Ditangco R. Effect of Macrolide Prophylactic Therapy on AIDS-Defining Conditions and HIV-Associated Mortality. J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):436-443. doi: 10.1097/QAI.0000000000001933. PubMed PMID: 30550488; PubMed Central PMCID: PMC6391185. (ISI-Indexed)
  • Tee YC, Earnshaw VA, Altice FL, Jin H, Kamarulzaman A, Wickersham JA. Evaluating Physicians' Intention to Discriminate Against Patients Living with HIV in Malaysia. AIDS Behav. 2019 Apr;23(4):1039-1047. (ISI-Indexed)
  • Bijker R, Jiamsakul A, Uy E, Kumarasamy N, Ditango R, Chaiwarith R, Wong WW, Avihingsanon A, Sun LP, Yunihastuti E, Pujari S, Do CD, Merati TP, Kantipong P, Nguyen KV, Kamarulzaman A, Zhang F, Lee MP, Choi JY, Tanuma J, Ng OT, Sim B, Ross J, Kiertiburanakul S; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2019 Mar;20(3):183-191. doi: 10.1111/hiv.12687. Epub 2019 Jan 8. PubMed PMID: 30620108; PubMed Central PMCID: PMC6422532. (ISI-Indexed)
  • Han WM, Jiamsakul A, Kiertiburanakul S, Ng OT, Sim BL, Sun LP, Van Nguyen K, Choi JY, Lee MP, Wong WW, Kamarulzaman A, Kumarasamy N, Zhang F, Tanuma J, Do CD, Chaiwarith R, Merati TP, Yunihastuti E, Pujari S, Ditangco R, Khusuwan S, Ross J, Avihingsanon A; IeDEA Asia-Pacific. Diabetes mellitus burden among people living with HIV from the Asia-Pacific region. J Int AIDS Soc. 2019 Jan;22(1):. (ISI-Indexed)
  • Pham MD, Haile BA, Azwa I, Kamarulzaman A, Raman N, Saeidi A, Kahar Bador M, Tan M, Zhu J, Feng Y, Elliott JH, Garcia ML, Li F, Crowe SM, Luchters S, Anderson DA. Performance of a Novel Low-Cost, Instrument-Free Plasma Separation Device for HIV Viral Load Quantification and Determination of Treatment Failure in People Living with HIV in Malaysia: a Diagnostic Accuracy Study. J Clin Microbiol. 2019 (ISI-Indexed)
  • Ahn MY, Jiamsakul A, Khusuwan S, Khol V, Pham TT, Chaiwarith R, Avihingsanon A, Kumarasamy N, Wong WW, Kiertiburanakul S, Pujari S, Nguyen KV, Lee MP, Kamarulzaman A, Zhang F, Ditangco R, Merati TP, Yunihastuti E, Ng OT, Sim BLH, Tanuma J, Ratanasuwan W, Ross J, Choi JY; IeDEA Asia-Pacific. The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV. J Int AIDS Soc. 2019 Feb;22(2):e25228. (ISI-Indexed)
  • Archuleta S, Chia PY, Wei Y, Syed-Omar SF, Low JG, Oh HM, Fisher D, Ponnampalavanar SSL, Wijaya L, Kamarulzaman A, Lum LCS, Tambyah PA, Leo YS, Lye DC. Predictors and Clinical Outcomes of Poor Platelet Recovery in Adult Dengue With Thrombocytopenia: A Multicenter, Prospective Study. Clin Infect Dis. 2019 Oct 18. (ISI-Indexed)
  • Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, Williams B, Gouws-Williams E, Ghys PD; WHO–UNAIDS Network for HIV Isolation Characterisation. Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis. Lancet Infect Dis. 2019 Feb;19(2):143-155. (ISI-Indexed)
  • Shrestha R, Lim SH, Altice FL, Copenhaver M, Wickersham JA, Saifi R, Ab Halim MA, Naning H, Kamarulzaman A. Use of Smartphone to Seek Sexual Health Information Online Among Malaysian Men Who Have Sex with Men (MSM): Implications for mHealth Intervention to Increase HIV Testing and Reduce HIV Risks. J Community Health. 2019 Aug 2. (ISI-Indexed)

2018
  • Vijay A, Earnshaw VA, Tee YC, Pillai V, White Hughto JM, Clark K, Kamarulzaman A, Altice FL, Wickersham JA. Factors Associated with Medical Doctors' Intentions to Discriminate Against Transgender Patients in Kuala Lumpur, Malaysia. LGBT Health. 2018 Jan;5(1):61-68. (ISI-Indexed)
  • Ng KT, Oong XY, Lim SH, Chook JB, Takebe Y, Chan YF, Chan KG, Hanafi NS, Pang YK, Kamarulzaman A, Tee KK. Viral Load and Sequence Analysis Reveal the Symptom Severity, Diversity, and Transmission Clusters of Rhinovirus Infections. Clin Infect Dis. 2018 Jul 2;67(2):261-268. (ISI-Indexed)
  • Naning H, Al-Darraji HAA, McDonald S, Ismail NA, Kamarulzaman A. Modelling the Impact of Different Tuberculosis Control Interventions on the Prevalence of Tuberculosis in an Overcrowded Prison. Asia Pac J Public Health. 2018 Apr;30(3):235-243. (ISI-Indexed)
  • Mukherjee T, Sakthivel R, Fong HY, McStea M, Chong ML, Omar SF, Chin AV, Kamaruzzaman S, Kamarulzaman A, Rajasuriar R, Cysique LA. Utility of Using the Montreal Cognitive Assessment (MoCA) as a Screening Tool for HIV-Associated Neurocognitive Disorders (HAND) In Multi-Ethnic Malaysia. AIDS Behav. 2018 Oct;22(10):3226-3233. (ISI-Indexed)
  • Mohd Salleh NA, Richardson L, Kerr T, Shoveller J, Montaner J, Kamarulzaman A, Milloy MJ. A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs. J Addict Med. 2018 Jul/Aug;12(4):308-314. (ISI-Indexed)
  • Abdul Aziz SA, Mcstea M, Ahmad Bashah NS, Chong ML, Ponnampalavanar S, Syed Omar SF, Sulaiman H, Azwa I, Tan MP, Kamarulzaman A, Rajasuriar R, Kamaruzzaman SB. Assessment of sarcopenia in virally suppressed HIV-infected Asians receiving treatment. AIDS. 2018 May 15;32(8):1025-1034. (ISI-Indexed)
  • Lim SH, Akbar M, Wickersham JA, Kamarulzaman A, Altice FL. The management of methamphetamine use in sexual settings among men who have sex with men in Malaysia. Int J Drug Policy. 2018 May;55:256-262. (ISI-Indexed)
  • Yong YK, Saeidi A, Tan HY, Rosmawati M, Enström PF, Batran RA, Vasuki V, Chattopadhyay I, Murugesan A, Vignesh R, Kamarulzaman A, Rajarajeswaran J, Ansari AW, Vadivelu J, Ussher JE, Velu V, Larsson M, Shankar EM. Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161(++)TCR iVα7.2(+) Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus Infection. Front Immunol. 2018 Mar 19;9:472. (ISI-Indexed)
  • Oong XY, Chook JB, Ng KT, Chow WZ, Chan KG, Hanafi NS, Pang YK, Chan YF, Kamarulzaman A, Tee KK. The role of human Metapneumovirus genetic diversity and nasopharyngeal viral load on symptom severity in adults. Virol J. 2018 May 23;15(1):91. (ISI-Indexed)
  • Bekker LG, Alleyne G, Baral S, Cepeda J, Daskalakis D, Dowdy D, Dybul M, Eholie S, Esom K, Garnett G, Grimsrud A, Hakim J, Havlir D, Isbell MT, Johnson L, Kamarulzaman A, Kasaie P, Kazatchkine M, Kilonzo N, Klag M, Klein M, Lewin SR, Luo C, Makofane K, Martin NK, Mayer K, Millett G, Ntusi N, Pace L, Pike C, Piot P, Pozniak A, Quinn TC, Rockstroh J, Ratevosian J, Ryan O, Sippel S, Spire B, Soucat A, Starrs A, Strathdee SA, Thomson N, Vella S, Schechter M, Vickerman P, Weir B, Beyrer C. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission. Lancet. 2018 Jul 28;392(10144):312-358. (ISI-Indexed)
  • Barré-Sinoussi F, Abdool Karim SS, Albert J, Bekker LG, Beyrer C, Cahn P, Calmy A, Grinsztejn B, Grulich A, Kamarulzaman A, Kumarasamy N, Loutfy MR, El Filali KM, Mboup S, Montaner JS, Munderi P, Pokrovsky V, Vandamme AM, Young B, Godfrey-Faussett P. Expert consensus statement on the science of HIV in the context of criminal law. J Int AIDS Soc. 2018 Jul;21(7):e25161. (ISI-Indexed)
  • Joshi K, Boettiger D, Kerr S, Nishijima T, Van Nguyen K, Ly PS, Lee MP, Kumarasamy N, Wong W, Kantipong P, Cuong DD, Kamarulzaman A, Choi JY, Zhang F, Chaiwarith R, Ng OT, Kiertiburanakul S, Sim BLH, Merati TP, Yunihastuti E, Ditangco R, Ross J, Pujari S. Changes in renal function with long-term exposure to antiretroviral therapy in HIV-infected adults in Asia. Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1209-1216. (ISI-Indexed)
  • Lim SH, Brown SE, Shaw SA, Kamarulzaman A, Altice FL, Beyrer C. "You Have to Keep Yourself Hidden": Perspectives From Malaysian Malay-Muslim Men Who Have Sex With Men on Policy, Network, Community, and Individual Influences on HIV Risk. J Homosex. 2018 Oct 11:1-23. (ISI-Indexed)
  • Rutledge R, Morozova O, Gibson BA, Altice FL, Kamarulzaman A, Wickersham JA. Correlates of Recent HIV Testing Among Transgender Women in Greater Kuala Lumpur, Malaysia. LGBT Health. 2018 Nov/Dec;5(8):484-493. doi: . Epub 2018 Nov 27. (ISI-Indexed)
  • Stacey A. Shaw, Olivia Cornwell, Sin How Lim, Rumana Saifi, Lik Teng Ung & Adeeba Kamarulzaman.“Allah will decide my life and death”: Religion and spirituality among populations at risk for HIV in Malaysia (ISI-Indexed)
  • Lee, S.C., Chua, L.L., Yap, S.H., Khang, T.F., Chan, Y.L., Azwa, I., Lewin, S.R., Kamarulzaman, A., Woo, Y.L., Lim, Y.A.L., Loke, P., Rajasuriar, R. (2018). Enrichment of gut-derived Fusobacterium is associated with suboptimal immune recovery in HIV-infected individuals. Scientific Reports, 8:14277. (ISI-Indexed)
  • McDonald SA, Azzeri A, Shabaruddin FH, Dahlui M, Tan SS, Kamarulzaman A, Mohamed R. Projections of the Healthcare Costs and Disease Burden due to Hepatitis C Infection under Different Treatment Policies in Malaysia, 2018-2040. Appl Health Econ Health Policy. 2018 Aug 25. doi: 10.1007/s40258-018-0425-3. (ISI-Indexed)
  • Khan F, Krishnan A, Ghani MA, Wickersham JA, Fu JJ, Lim SH, Dhaliwal SK, Kamarulzaman A, Altice FL. Assessment of an Innovative Voluntary Substance Abuse Treatment Program Designed to Replace Compulsory Drug Detention Centers in Malaysia. Subst Use Misuse. 2018 Jan 28;53(2):249-259. (ISI-Indexed)
  • Azzeri A, Shabaruddin FH, , Tan SS, Dahlui M, McDonald SA, Kamarulzaman A, Mohamed R. CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC HEPATITIS C INFECTION AT INITIAL PRESENTATION TO TERTIARY CARE IN AN ASIAN MIDDLE-INCOME COUNTRY (ISI-Indexed)

2017
  • Lim LM, McStea M, Chung WW, Nor Azmi N, Abdul Aziz SA, Alwi S, Kamarulzaman A, Kamaruzzaman SB,Chua SS, Rajasuriar R.Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia. (ISI-Indexed)
  • Oong XY, Ng KT, Takebe Y, Ng LJ, Chan KG, Chook JB, Kamarulzaman A, Tee KK.Identification and evolutionary dynamics of two novel human coronavirus OC43 genotypes associated with acute respiratory infections: phylogenetic, spatiotemporal and transmission network analyses. (ISI-Indexed)
  • Wegman MP, Altice FL, Kaur S, Rajandaran V, Osornprasop S, Wilson D, Wilson DP, Kamarulzaman A.Relapse to opioid use in opioid-dependent individuals released from compulsory drug detention centres compared with those from voluntary methadone treatment centres in Malaysia: a two-arm, prospective observational study. (ISI-Indexed)
  • Durier N, Yunihastuti E, Ruxrungtham K, Kinh NV, Kamarulzaman A, Boettiger D, Widhani A, Avihingsanon A, Huy BV, Syed Omar SF, Sanityoso A, Chittmittrapap S, Dung NT, Pillai V, Suwan-Ampai T, Law M, Sohn AH, Matthews G. Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia. . (ISI-Indexed)
  • Leng CY, Low HC, Chua LL, Chong ML, Sulaiman H, Azwa I, Roberts JM, Kamarulzaman A, Rajasuriar R, Woo YL.Human papillomavirus 16 (HPV16) and HPV52 E6-specific immunity in HIV-infected adults on combination antiretroviral therapy. (ISI-Indexed)
  • Beyrer C, Kamarulzaman A. Ethnic cleansing in Myanmar: the Rohingya crisis and human rights. Lancet. 2017 Sep 30;390(10102):1570-1573. (ISI-Indexed)
  • Lye, D. C., Archuleta, S., Syed-Omar, S. F., Low, J. G., Oh, H. M., Wei, Y., ... & Ooi, E. E. (2017). Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial. The Lancet, 389(10079), 1611-1618. (ISI-Indexed)
  • Yap SH, Abdullah NK, McStea M, Takayama K, Chong ML, Crisci E, Larsson M, Azwa I, Kamarulzaman A, Leong KH, Woo YL, Rajasuriar R. HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution. PLoS One. 2017 Oct 9;12(10):e0186000. . (ISI-Indexed)
  • Kiertiburanakul S, Boettiger D, Ng OT, Van Kinh N, Merati TP, Avihingsanon A, Wong WW, Lee MP, Chaiwarith R, Kamarulzaman A, Kantipong P, Zhang F, Choi JY, Kumarasamy N, Ditangco R, Cuong DD, Oka S, Sim BLH, Ratanasuwan W, Ly PS, Yunihastuti E, Pujari S, Ross JL, Law M, Sungkanuparph S; TREAT Asia HIV Observational Databases (TAHOD). Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings. AIDS Res Ther. 2017 May 5;14:27. (ISI-Indexed)
  • Jung IY, Boettiger D, Wong WW, Lee MP, Kiertiburanakul S, Chaiwarith R, Avihingsanon A, Tanuma J, Kumarasamy N, Kamarulzaman A, Zhang F, Kantipong P, Ng OT, Sim BLH, Law M, Ross J, Choi JY. The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the TREAT Asia HIV Observational Database (TAHOD). J Int AIDS Soc. 2017 Dec;20(4). (ISI-Indexed)
  • Mukherjee TI, Pillai V, Ali SH, Altice FL, Kamarulzaman A, Wickersham JA. Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia. Int J Drug Policy. 2017 Sep;47:144-152. (ISI-Indexed)
  • Tee KK, Bon AH, Chow WZ, Ng KT, Chan KG, Kamarulzaman A, Busch MP, Takebe Y. Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF77_cpx) Identified among Blood Donors in Malaysia. Genome Announc. 2017 Jun 29;5(26). pii: e00459-17. doi: . PubMed PMID: 28663289; PubMed Central PMCID: PMC5638273. (ISI-Indexed)
  • Wickersham JA, Gibson BA, Bazazi AR, Pillai V, Pedersen CJ, Meyer JP, El-Bassel N, Mayer KH, Kamarulzaman A, Altice FL. Prevalence of Human Immunodeficiency Virus and Sexually Transmitted Infections Among Cisgender and Transgender Women Sex Workers in Greater Kuala Lumpur, Malaysia: Results From a Respondent-Driven Sampling Study. Sex Transm Dis. 2017 Nov;44(11):663-670. (ISI-Indexed)
  • Lall P, Shaw SA, Saifi R, Sherman S, Azmi NN, Pillai V, El-Bassel N, Kamarulzaman A, Wickersham JA. Acceptability of a microfinance-based empowerment intervention for transgender and cisgender women sex workers in Greater Kuala Lumpur, Malaysia. J Int AIDS Soc. 2017 Aug 2;20(1):21723. (ISI-Indexed)
  • Bazazi AR, Vijay A, Crawford FW, Heimer R, Kamarulzaman A, Altice FL. HIV Testing and awareness of HIV status among people who inject drugs in greater Kuala Lumpur, Malaysia. AIDS Care. 2018 Jan;30(1):59-64. (ISI-Indexed)
  • Rajasuriar, R., Chong, M. L., Bashah, A., Nor, S., Abdul Aziz, S. A., Mcstea, M., ... & Sharifah, F. (2017). Major health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy. Aids, 31(10), 1393-1403. (ISI-Indexed)
  • Naidu, S., Ponnampalvanar, S., Kamaruzzaman, S. B., & Kamarulzaman, A. (2017). Prevalence of metabolic syndrome among people living with HIV in developing countries: a systematic review. AIDS patient care and STDs, 31(1), 1-13. (ISI-Indexed)
  • Ahmad F, Shankar EM, Yong YK, Tan HY Ahrenstorf G, Jacobs R, Larsson M, Schmidt RE, Kamarulzaman A, Ansari AW.Negative Checkpoint Regulatory Molecule 2B4 (CD244) Upregulation Is Associated with Invariant Natural Killer T Cell Alterations and Human Immunodeficiency Virus Disease Progression. (ISI-Indexed)
  • San Sit, P., Teh, C. S. J., Idris, N., Sam, I. C., Omar, S. F. S., Sulaiman, H., ... & Ponnampalavanar, S. (2017). Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysia. BMC infectious diseases, 17(1), 274. (ISI-Indexed)

2016
  • Michalopoulos LM, Jiwatram-Negrón T, Choo MK, Kamarulzaman A, El-Bassel N.The association between psychosocial and structural-level stressors and HIV injection drug risk behavior among Malaysian fishermen: A cross-sectional study. (ISI-Indexed)
  • Krishnan A, Brown SE, Ghani MA, Khan F, Kamarulzaman A, Altice FL.Pretreatment drug use characteristics and experiences among patients in a voluntary substance abuse treatment center in Malaysia: A mixed-methods approach. (ISI-Indexed)
  • Al-Khannaq MN, Ng KT, Oong XY, Pang YK, Takebe Y, Chook JB, Hanafi NS, Kamarulzaman A, Tee KK.Diversity and Evolutionary Histories of Human Coronaviruses NL63 and 229E Associated with Acute Upper Respiratory Tract Symptoms in Kuala Lumpur, Malaysia. (ISI-Indexed)
  • Chen M, Wong WW, Law MG, Kiertiburanakul S, Yunihastuti E, Merati TP, Lim PL, Chaiwarith R, Phanuphak P, Lee MP, Kumarasamy N, Saphonn V, Ditangco R, Sim BL, Nguyen KV, Pujari S, Kamarulzaman A, Zhang F, Pham TT, Choi JY, Oka S, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Chen YM.Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival. (ISI-Indexed)
  • Jiamsakul A, Kerr SJ, Ng OT, Lee MP, Chaiwarith R, Yunihastuti E, Van Nguyen K, Pham TT, Kiertiburanakul S, Ditangco R, Saphonn V, Sim BL, Merati TP, Wong W, Kantipong P, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Oka S, Mustafa M, Ratanasuwan W, Petersen B, Law M, Kumarasamy N; TREAT Asia HIV Observational Database (TAHOD).Effects of unplanned treatment interruptions on HIV treatment failure - results from TAHOD. (ISI-Indexed)
  • Tan HY, Yong YK, Shankar EM, Paukovics G, Ellegård R, Larsson M, Kamarulzaman A, French MA, Crowe SM.Aberrant Inflammasome Activation Characterizes Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome (ISI-Indexed)
  • Csete J, Kamarulzaman A, Kazatchkine M, Altice F, Balicki M, Buxton J, Cepeda J, Comfort M, Goosby E, Goulão J, Hart C, Kerr T, Lajous AM, Lewis S, Martin N, Mejía D, Camacho A, Mathieson D, Obot I, Ogunrombi A, Sherman S, Stone J, Vallath N, Vickerman P, Zábranský T, Beyrer C.Public health and international drug policy. (ISI-Indexed)
  • Lall P, Saifi R, Kamarulzaman A.Tobacco Consumption Among HIV-Positive Respondents: Findings From the Third Round of the National Family Health Survey. (ISI-Indexed)
  • Azanan MS, Abdullah NK, Chua LL, Lum SH, Abdul Ghafar SS, Kamarulzaman A, Kamaruzzaman S, Lewin SR, Woo YL, Ariffin H, Rajasuriar R.Immunity in young adult survivors of childhood leukemia is similar to the elderly rather than age-matched controls: Role of cytomegalovirus. . (ISI-Indexed)
  • Al-Darraji HA, Altice FL, Kamarulzaman A.Undiagnosed pulmonary tuberculosis among prisoners in Malaysia: an overlooked risk for tuberculosis in the community. (ISI-Indexed)
  • Mukherjee T Wickersham JA, Desai MM, Pillai V, Kamarulzaman A, Altice FL.Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia. (ISI-Indexed)
  • Culbert GJ, Pillai V, Bick J, Al-Darraji HA, Wickersham JA, Wegman MP, Bazazi AR, Ferro E, Copenhaver M, Kamarulzaman A, Altice FL.Confronting the HIV, Tuberculosis, Addiction, and Incarceration Syndemic in Southeast Asia: Lessons Learned from Malaysia. (ISI-Indexed)
  • Yong YK, Shankar EM, Solomon A, Spelman T, Fairley CK, Elliott JH, Hoy J, Cameron PU, Kamarulzaman A, Lewin SR.Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy. (ISI-Indexed)
  • Lunze K, Idrisov B, Golichenko M, Kamarulzaman A.Mandatory addiction treatment for people who use drugs: global health and human rights analysis. (ISI-Indexed)
  • Lam EP, Moore CL, Gotuzzo E, Nwizu C, Kamarulzaman A, Chetchotisakd P, van Wyk J, Teppler H, Kumarasamy N, Molina JM, Emery S, Cooper DA, Boyd MA.Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study. (ISI-Indexed)
  • Rahman F, Kamarulzaman A.Southeast Asia in focus: stemming the reawakening of prohibitionism. (ISI-Indexed)
  • . Brown SE, Wickersham JA, Pelletier AR, Marcus RM, Erenrich R, Kamarulzaman A, Altice FL.Attitudes toward medication-assisted treatment among fishermen in Kuantan, Malaysia, who inject drugs. (ISI-Indexed)
  • Beyrer C, Kamarulzaman A, McKee M; Lancet HIV in Prisoners Group.Prisoners, prisons, and HIV: time for reform. (ISI-Indexed)
  • Kamarulzaman A, Reid SE, Schwitters A, Wiessing L, El-Bassel N, Dolan K, Moazen B, Wirtz AL, Verster A, Altice FL.Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. . (ISI-Indexed)
  • Do TC, Boettiger D, Law M, Pujari S, Zhang F, Chaiwarith R, Kiertiburanakul S, Lee MP, Ditangco R, Wong WW, Nguyen KV, Merati TP, Pham TT, Kamarulzaman A, Oka S, Yunihastuti E, Kumarasamy N, Kantipong P, Choi JY, Ng OT, Durier N, Ruxrungtham K.Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort. (ISI-Indexed)
  • Yong YK, Shankar EM, Westhorpe CL, Maisa A, Spelman T, Kamarulzaman A, Crowe SM, Lewin SR.Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy. (ISI-Indexed)
  • Nasarruddin AM, Saifi RA, Othman S, Kamarulzaman A.Opening up the HIV epidemic: a review of HIV seropositive status disclosure among people who inject drugs. (ISI-Indexed)
  • Tanuma J, Jiamsakul A, Makane A, Avihingsanon A, Ng OT, Kiertiburanakul S, Chaiwarith R, Kumarasamy N, Nguyen KV, Pham TT, Lee MP, Ditangco R, Merati TP, Choi JY, Wong WW, Kamarulzaman A, Yunihastuti E, Sim BL, Ratanasuwan W, Kantipong P, Zhang F, Mustafa M, Saphonn V, Pujari S, Sohn AH; TREAT Asia HIV Observational Databases (TAHOD).Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific. (ISI-Indexed)
  • Chow WZ, Bon AH, Keating S, Anderios F, Halim HA, Takebe Y, Kamarulzaman A, Busch MP, Tee KK. Extensive Genetic Diversity of HIV-1 in Incident and Prevalent Infections among Malaysian Blood Donors: Multiple Introductions of HIV-1 Genotypes from Highly Prevalent Countries. (ISI-Indexed)
  • Zelenev A, Long E, Bazazi AR, Kamarulzaman A, Altice FL.The complex interplay of social networks, geography and HIV risk among Malaysian Drug Injectors: Results from respondent-driven sampling. . (ISI-Indexed)
  • Ku NS, Jiamsakul A, Ng OT, Yunihastuti E, Cuong do D, Lee MP, Sim BL, Phanuphak P, Wong WW, Kamarulzaman A, Zhang F, Pujari S, Chaiwarith R, Oka S, Mustafa M, Kumarasamy N, Van Nguyen K, Ditangco R, Kiertiburanakul S, Merati TP, Durier N, Choi JY; TREAT Asia HIV Observational Databases (TAHOD).Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy. (ISI-Indexed)
  • Bick J,Culbert G, Al-Darraji HA,Koh C, Pillai V, Kamarulzaman A, Altice F.Healthcare resources are inadequate to address the burden of illness among HIV-infected male prisoners in Malaysia. (ISI-Indexed)
  • Earnshaw VA, Jin H, Wickersham JA, Kamarulzaman A, John J, Lim SH, and Altice FL. 2016. Stigma Toward Men Who Have Sex with Men Among Future Healthcare Providers in Malaysia: Would More Interpersonal Contact Reduce Prejudice? AIDS and Behavior Jan;20(1):98-106.DOI 10.1007/s10461-015-1168-x (ISI-Indexed)
  • Al-Khannaq MN, Ng KT, Oong XY, Pang YK, Takebe Y, Chook JB, Hanafi NS, Kamarulzaman A, Tee KK. 2016. Molecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, Malaysia. Virol J 2016; 13(1):33. (ISI-Indexed)
  • Al-Khannaq, M.N., Ng, K.T., Oong, X.Y., Pang, Y.K., Takebe, Y., Chook, J.B., Hanafi, N.S., Kamarulzaman, A. and Tee, K.K., 2016. Diversity and Evolutionary Histories of Human Coronaviruses NL63 and 229E Associated with Acute Upper Respiratory Tract Symptoms in Kuala Lumpur, Malaysia.The American journal of tropical medicine and hygiene, pp.15-0810. (ISI-Indexed)
  • Gender identity, healthcare access, and risk reduction among Malaysia's mak nyah community Britton A. Gibson, Shan-Estelle Brown, Ronnye Rutledge, Jeffrey A. Wickersham, Adeeba Kamarulzaman & Frederick L. Altice (ISI-Indexed)
  • Chow WZ, Chan YF, Oong XY, Ng LJ, Nor E SS, Ng KT, Chan KG, Hanafi NS, Pang YK, Kamarulzaman A, Tee KK. Genetic diversity, seasonality and transmission network of human metapneumovirus: identification of a unique sub-lineage of the fusion and attachment genes. Sci Rep 2016; 6:27730. (ISI-Indexed)
  • Ng KT, Chook JB, Oong XY, Chan YF, Chan KG, Hanafi NS, Pang YK, Kamarulzaman A, Tee KK. Performance of a Taqman assay for improved detection and quantification of human rhinovirus viral load. Sci Rep 2016; 6:34855. (ISI-Indexed)

2015
  • Lum, L. C., Omar, S. F. S., Ponnampalavanar, S. S. L. S., Tan, L. H., Sekaran, S. D., & Kamarulzaman, A. (2015). Cohorting dengue patients improves the quality of care and clinical outcome. PLoS neglected tropical diseases, 9(6), e0003836. (ISI-Indexed)
  • McDonald SA, Dahlui M, Mohamed R, Naning H, Shabaruddin FH, et al. (2015) Projections of the Current and Future Disease Burden of Hepatitis C Virus Infection in Malaysia. PLoS ONE 10(6): e0128091. doi: 10.1371/journal.pone.0128091 (ISI-Indexed)
  • Alireza Saeidi1,2, Vicky L. Tien Tien3, Rami Al-Batran4 , Haider A. Al-Darraji2, Hong Y. Tan2,Yean K. Yong2,Sasheela Ponnampalavanar2, Muttiah Barathan1, Devi V. Rukumani1,Abdul W. Ansari2, Vijayakumar Velu5, Adeeba Kamarulzaman2, Marie Larsson6, EsakiM. Shankar1,2* (ISI-Indexed)
  • Sarah Larney, PhD,Bradley M. Mathers, MD,Tonia Poteat, MMSc, MPH, PhD, Adeeba Kamarulzaman k and Louisa Degenhardt, PhD (ISI-Indexed)
  • Tan, H. Y., Yong, Y. K., Andrade, B. B., Shankar, E. M., Ponnampalavanar, S., Omar, S. F., ... & Crowe, S. M. (2015). Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. Aids, 29(4), 421-431. (ISI-Indexed)
  • Lim, M. K., Lai, P. S. M., Ponnampalavanar, S. S. L. S., Omar, S. F. S., Taib, N. A., Yusof, M. Y., ... & Kamarulzaman, A. (2015). Antibiotics in surgical wards: use or misuse? A newly industrialized country’s perspective. The Journal of Infection in Developing Countries, 9(11), 1264-1271. (ISI-Indexed)
  • Jiamsakul A, Chaiwarith R, Durier N, Sirivichayakul S, Kiertiburanakul S, Van Den Eede P, Ditangco R, Kamarulzaman A, Li PC, Ratanasuwan W, Sirisanthana T; TREAT Asia Studies to Evaluate Resistance-Monitoring Study TASER-M. Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals. J Med Virol. 2015 Jul 3. (ISI-Indexed)
  • Ng KT, Oong XY, Pang YK, Hanafi NS, Kamarulzaman A, Tee KK. Outbreaks of enterovirus D68 in Malaysia: genetic relatedness to the recent US outbreak strains. Emerging microbes & infections 2015;4(8), p.e47. (ISI-Indexed)
  • Tanguay P, Kamarulzaman A, Aramrattana A, Wodak A, Thomson N, Ali R, Vumbaca G, Lai G, Chabungbam A. Facilitating a transition from compulsory detention of people who use drugs towards voluntary community-based drug dependence treatment and support services in Asia. (ISI-Indexed)
  • Tien Ng K, Takebe Y, Bee Chook J, Zhen Chow W, Gan Chan K, Abed Al-Darraji HA, Kamarulzaman A, Keng Tee K. Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs. Sci Rep. 2015 Oct 13;5:15198. (ISI-Indexed)
  • Loeliger KB, Marcus R, Wickersham JA, Pillai V, Kamarulzaman A, Altice FL. The syndemic of HIV, HIV-related risk and multiple co- morbidities among women who use drugs in Malaysia: Important targets for intervention. Addict Behav. 2015 Sep 25;53:31-39. (ISI-Indexed)
  • Oyomopito RA, Chen YJ, Sungkanuparph S, Kantor R, Merati T, Yam WC, Sirisanthana T, Li PC, Kantipong P, Phanuphak P, Lee CK, Kamarulzaman A, Ditangco R, Huang SW, Sohn AH, Law M, Chen YM. Risk group characteristics and viral transmission clusters in South-East Asian patients infected with human immunodeficiency virus-1 (HIV-1) circulating recombinant form (CRF) 01_AE and subtype B. Kaohsiung J Med Sci. 2015 Sep;31(9):445-53. (ISI-Indexed)
  • Bazazi AR, Crawford F, Zelenev A, Heimer R, Kamarulzaman A, Altice FL. HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling. AIDS Behav. 2015 Dec;19(12):2347-57. (ISI-Indexed)
  • Chow WZ, Lim SH, Ong LY, Yong YK, Takebe Y, Kamarulzaman A, Tee KK. Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients. PLoS One. 2015 Sep 3;10(9):e0137281. (ISI-Indexed)
  • Choo MK, El-Bassel N, Adam PC, Gilbert L, Wu E, West BS, Bazazi AR, De Wit JB, Ismail R, Kamarulzaman A. Prevalence and Correlates of HIV and Hepatitis C Virus Infections and Risk Behaviors among Malaysian Fishermen. PLoS One. 2015 Aug 5;10(8):e0118422. (ISI-Indexed)
  • Cheong HT, Chow WZ, Takebe Y, Chook JB, Chan KG, Al- Darraji HA, Koh C, Kamarulzaman A, Tee KK. Genetic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF74_01B) Identified among Intravenous Drug Users in Malaysia: Recombination History and Phylogenetic Linkage with Previously Defined Recombinant Lineages. PLoS One. 2015 Jul 21;10(7):e0133883. (ISI-Indexed)
  • Chan KG, Ng KT, Chong TM, Pang YK, Kamarulzaman A, Yin WF, Tee KK. Antibiotic Resistant and Virulence Determinants of Staphylococcus haemolyticus C10A as Revealed by Whole Genome Sequencing. J Genomics. 2015 Jun 3;3:72-4 (ISI-Indexed)
  • Saeidi A, Chong YK, Yong YK, Tan HY, Barathan M, Rajarajeswaran J, Sabet NS, Sekaran SD, Ponnampalavanar S, Che KF, Velu V, Kamarulzaman A, Larsson M, Shankar EM. Concurrent loss of co-stimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection. Cell Immunol. 2015 Sep;297(1):19-32 (ISI-Indexed)
  • Saeidi A, Chong YK, Yong YK, Tan HY, Barathan M, Rajarajeswaran J, Sabet NS, Sekaran SD, Ponnampalavanar S, Che KF, Velu V, Kamarulzaman A, Larsson M, Shankar EM. Concurrent loss of co-stimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection. Cell Immunol. 2015 Sep;297(1):19-32 (ISI-Indexed)
  • Boettiger DC, Kerr S, Ditangco R, Chaiwarith R, Li PC, Merati TP, Pham TT, Kiertiburanakul S, Kumarasamy N, Vonthanak S, Lee CK, Van Kinh N, Pujari S, Wong WW, Kamarulzaman A, Zhang F, Yunihastuti E, Choi JY, Oka S, Ng OT, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Law M; TREAT Asia HIV Observational Database. Tenofovir-based antiretroviral therapy in HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database. Antivir Ther. 2015 Jun 12 (ISI-Indexed)
  • Chan KG, Ng KT, Pang YK, Chong TM, Kamarulzaman A, Yin WF, Tee KK. Genome Anatomy of Streptococcus parasanguinis Strain C1A, Isolated from a Patient with Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Reveals Unusual Genomic Features. Genome Announc. 2015 May 28;3(3) (ISI-Indexed)
  • Ansari AW, Ahmad F, Meyer-Olson D, Kamarulzaman A, Jacobs R, Schmidt RE. Natural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis. Cell Mol Life Sci. 2015 Aug;72(16):3037-49 (ISI-Indexed)
  • Wright ST, Law MG, Cooper DA, Keen P, McDonald A, Middleton M, Woolley I, Kelly M, Petoumenos K; Australian HIV Observational Database. Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia. J Int AIDS Soc. 2015 Apr 10;18:19463 (ISI-Indexed)
  • Ahn JY, Boettiger D, Law M, Kumarasamy N, Yunihastuti E, Chaiwarith R, Lee MP, Sim BL, Oka S, Wong W, Kamarulzaman A, Kantipong P, Phanuphak P, Ng OT, Kiertiburanakul S, Zhang F, Pujari S, Ditangco R, Ratanasuwan W, Merati TP, Saphonn V, Sohn AH, Choi JY; TREAT Asia HIV Observational Databases (TAHOD). Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression. J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):e85-92 (ISI-Indexed)
  • Vijay A, Bazazi AR, Yee I, Kamarulzaman A, Altice FL. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia. J Subst Abuse Treat. 2015 Jul;54:29-36. (ISI-Indexed)
  • Tee KK, Kantor R, Sungkanuparph S, Takebe Y, Li P, Ditangco R, Phanuphak P, Sirisanthana T, Sim B, Ratanasuwan W, Kantipong P, Kamarulzaman A. Transmission Networks of HIV-1 Among Men Who Have Sex With Men in East and Southeast Asia. J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):e28-30. (ISI-Indexed)
  • Al-Darraji HA, Tan C, Kamarulzaman A, Altice FL. Prevalence and correlates of latent tuberculosis infection among employees of a high security prison in Malaysia. Occup Environ Med. 2015 Jun;72(6):442-7. (ISI-Indexed)
  • Lee MP, Zhou J, Messerschmidt L, Honda M, Ditangco R, Sirisanthana T, Kumarasamy N, Phanuphak P, Chen YM, Zhang F, Saphonn V, Kiertiburanakul S, Lee CK, Pujari S, Choi JY, Kamarulzaman A, Yunihastuti E, Merati TP, Lim PL, Li PC; TREAT Asia HIV Observational Database. Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database. AIDS Patient Care STDS. 2015 May;29(5):229-31.Epub 2015 Mar 16 (ISI-Indexed)
  • Barathan M, Mohamed R, Saeidi A, Vadivelu J, Chang LY, Gopal K, Ram MR, Ansari AW, Kamarulzaman A, Velu V, Larsson M, Shankar EM. Increased frequency of late-senescent T cells lacking CD127 in chronic hepatitis C disease. Eur J Clin Invest. 2015 May;45(5):466-74. (ISI-Indexed)
  • Culbert GJ, Waluyo A, Iriyanti M, Muchransyah AP, Kamarulzaman A, Altice FL. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice. Drug Alcohol Depend. 2015 Apr 1;149:71-9. (ISI-Indexed)
  • Bazazi AR, Zelenev A, Fu JJ, Yee I, Kamarulzaman A, Altice FL. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study. Int J Drug Policy. 2015 Jul;26(7):675-81. (ISI-Indexed)
  • Oong XY, Ng KT, Lam TTY, Pang YK, Chan KG, Hanafi NS, Kamarulzaman A, Tee KK. Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012-2014. PloS ONE 2015;10(8), p.e0136254 (ISI-Indexed)

2014
  • Tan, H. Y., Yong, Y. K., Lim, S. H., Ponnampalavanar, S., Omar, S. F., Pang, Y. K., ... & French, M. A. (2014). Tuberculosis (TB)-associated immune reconstitution inflammatory syndrome in TB-HIV co-infected patients in Malaysia: prevalence, risk factors, and treatment outcomes. Sexual health, 11(6), 532-539. (ISI-Indexed)
  • Ong, L. Y., Razak, S. N. H., Lee, Y. M., Sri La Sri Ponnampalavanar, S., Syed Omar, S. F., Azwa, R. I., ... & Kamarulzaman, A. (2014). Molecular diversity of HIV‐1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia. Journal of medical virology, 86(1), 38-44. (ISI-Indexed)
  • Harry Jin, Valerie A. Earnshaw, Jeffrey A. Wickersham, Adeeba Kamarulzaman, Mayur M. Desai, Jacob John & Frederick L. Altice 2014. An assessment of health-care students' attitudes toward patients with or at high risk for HIV: implications for education and cultural competency. AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV,DOI: 10.1080/09540121.2014.894616 (ISI/SCOPUS Indexed Publication)

2013
  • Ng KT, Lee YM, Al-Darraji HA, Xia X, Takebe Y, Chan KG, Lu L, Mahadeva S, Kamarulzaman A, Tee KK. 
  • Lee SS, Meintjes G, Kamarulzaman A, Leung CC 
  • Kamarulzaman A 
  • Lim SH, Bazazi AR, Sim C, Choo M, Altice FL, Kamarulzaman A 
  • Kiertiburanakul S, Chaiwarith R, Sirivichayakul S, Ditangco R, Jiamsakul A, Li PC, Kantipong P, Lee C, Ratanasuwan W, Kamarulzaman A, Sohn AH, Sungkanuparph S; for the TREAT Asia Studies to Evaluate Resistance Surveillance and Monitoring Studies. 
  • Abed Al-Darraji HA, Abd Razak H, Ng KP, Altice FL, Kamarulzaman A 
  • Wickersham JA,Zahari MM,Azar MM,Kamarulzaman A,Altice FL 
  • Ng KT, Ong LY, Lim SH, Takebe Y, Kamarulzaman A, Tee KK 
  • Lubis R, Bulgiba A, Kamarulzaman A, Hairi NN, Dahlui M, Peramalah D 
  • Larsson M, Shankar EM, Che KF, Saeidi A, Elleg� R, Barathan M, Velu V, Kamarulzaman A. 
  • Chow WZ, Ong LY, Razak SH, Lee YM, Ng KT, Yong YK, Azmel A, Takebe Y, Al-Darraji HA, Kamarulzaman A, Tee KK 
  • Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A 
  • Wright S, Boyd MA, Yunihastuti E, Law M, Sirisanthana T, Hoy J, Pujari S, Lee MP, Petoumenos K; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia- Pacific HIV Observational Database (APHOD). 
  • Cooke GS, Lemoine M, Thursz M, Gore C, Swan T, Kamarulzaman A, DuCros P, Ford N. 
  • Mohd Zim MA, Sam IC, Omar SF, Cahn YF,Abu Bakar S,Kamarulzaman A. Chikungunya infection in Malaysia:Comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol.2013 
  • Reena Rajasuriara,Gabriela Khouryc,Adeeba Kamarulzaman, Martyn A. Frenche,Paul U.Cameronc,and Sharon R. Lewinc 

2012
  • Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, van Vugt M, Rinke de Wit TF; PharmAccess African PASER and TREAT Asia Studies to Evaluate Resistance 
  • Ford N, Kirby C, Singh K, Mills EJ, Cooke G, Kamarulzaman A,duCros P. 
  • Smolak A, Gorroochurn P, Kamarulzaman A, Janjua N 
  • Chow WZ, Al-Darraji H, Lee YM, Takebe Y, Kamarulzaman A, Tee KK. 
  • Ng KT, OngLY, Takabe Y, Kamarulzaman A, Tee KK, 
  • Chong YB, Tan LP, Robinson S, Lim SK, Ng KP, Keng TC, Kamarulzaman A. Penicilliosis in lupus patients presenting with unresolved fever: A report of 2 cases and literature review. Tropical Biomedicine 29(2):270- 276 (2012) (ISI-Indexed)
  • Tee KK, Kamarulzaman A, Matano T, Takebe Y. Future Virol. (2012) 7(4), 405-414 (ISI-Indexed)
  • Ford N, Singh K, Cooke GS, Mills EJ, von Schoen- Angerer T, Kamarulzaman A, du Cros P. Clin Infect Dis. 2012 May;54(10):1465-72. Epub 2012 Mar 19. (ISI-Indexed)
  • Aghafar MZ, Witt C, Kamarulzaman A, Ismail R, Lederman MM, Rodriguez B, Senitzer D, Lee S, Price P. Tissue Antigens.¿2012 May;79(5):367-71. doi: 10.1111/j.1399-0039.2012.01843.x. Epub 2012 Feb 2. (ISI-Indexed)
  • Al-Darraji HA, Kamarulzaman A, Altice FL. Int J Tuberc Lung Dis. 2012 Jul;16(7):871-9. Epub 2012 Mar 7. (ISI-Indexed)
  • Zhou J, Tanuma J, Chaiwarith R, Lee CK, Law MG, Kumarasamy N, Phanuphak P, Chen YM, Kiertiburanakul S, Zhang F, Vonthanak S, Ditangco R, Pujari S, Choi JY, Parwati Merati T, Yunihastuti E, Li PC, Kamarulzaman A, Nguyen VK, Thuy Pham TT, Lim PL. AIDS Res Treat. 2012;2012:375217. Epub 2012 Feb 22. (ISI-Indexed)
  • Lim PL, Zhou J, Ditangco RA, Law MG, Sirisanthana T, Kumarasamy N, Chen YM, Phanuphak P, Lee CK, Saphonn V, Oka S, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Li PC, Merati TP, Yunihastuti E, Messerschmidt L, Sungkanuparph S; TREAT Asia HIV Observational Database. J Int AIDS Soc. 2012 Jan 26;15(1):1. (ISI-Indexed)
  • Azzoni L, Foulkes AS, Liu Y, Li X, Johnson M, Smith C, Kamarulzaman AB, Montaner J, Mounzer K, Saag M, Cahn P, Cesar C, Krolewiecki A, Sanne I, Montaner LJ. PLoS Med. 2012;9(4):e1001207. Epub 2012 Apr 17. (ISI-Indexed)
  • Jeffrey A Wickersham,Ruthanne Marcus,Adeeba Kamarulzaman, Muhammad Muhsin Zaharib & Frederick L Altice 
  • Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A. Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers. PLoS One. 2012;7(9):e44249. doi: 10.1371/journal.pone.0044249. Epub 2012 Sep 18. 
  • Jiamsakul A, Kantor R, Li PC, Sirivichayakul S, Sirisanthana T, Kantipong P, Lee CK, Kamarulzaman A, Ratanasuwan W, Ditangco R, Singtoroj T, Sungkanuparph S; On behalf of the TREAT Asia Studies to Evaluate Resistance Monitoring Study (TASER-M). Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-na HIV-infected patients in Asia: TASER-M cohort analysis. BMC Res Notes. 2012 Oct 24;5(1):582. 
  • Oyomopito RA, Li PC, Sungkanuparph S, Phanuphak P, Tee KK, Sirisanthana T, Kantipong P, Oka S, Lee CK, Kamarulzaman A, Choi JY, Sohn AH, Law M, Chen YM; on behalf of the TREAT Asia Studies to Evaluate Resistance (TASER) and the TREAT Asia HIV Observational Database. Evaluating immunologic response and clinical deterioration in treatment-na� patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B. J Acquir Immune Defic Syndr. 2012 Nov 7 
  • Sam IC, Karunakaran R, Kamarulzaman A, Ponnampalavanar S, Syed Omar SF, Ng KP, Mohd Yusof MY, Hooi PS, Jafar FL, Abubakar S. A large exposure to Brucella melitensis in a diagnostic laboratory. J Hosp Infect 2012; 80(4):321-5. (ISI-Indexed)

2011
  • Kanter J, Koh C, Razali K, Tai R, Izenberg J, Rajan L, Van Griensven F, Kamarulzaman A. Risk behaviour and HIV prevalence among men who have sex with men in a multiethnic society: a venue-based study in Kuala Lumpur, Malaysia. Int J STD AIDS. 2011 Jan;22(1):30-7. 
  • Sungkanuparph S, Oyomopito R, Sirivichayakul S, Sirisanthana T, Li PC, Kantipong P, Lee CK, Kamarulzaman A, Messerschmidt L, Law MG, Phanuphak P; TREAT Asia Studies to Evaluate Resistance-Monitoring Study (TASER-M). HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study. Clin Infect Dis. 2011 Apr 15;52(8):1053-7. 
  • Tan DB, Yong YK, Lim A, Tan HY, Kamarulzaman A, French M, Price P. Robust interferon-¿nd IL-12 responses by dendritic cells are related to efficient CD4(+) T-cell recovery in HIV patients on ART. Clin Immunol. 2011May;139(2):115-21. Epub 2011 Feb 23 
  • Bachireddy C, Bazazi AR, Kavasery R, Govindasamy S, Kamarulzaman A, Altice FL. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: Implications for secondary prevention. Drug Alcohol Depend. 2011 Jan 11. 
  • Tan LH, Fong MY, Mahmud R, Muslim A, Lau YL, Kamarulzaman A. (2011). Zoonotic Brugia pahangi filariasis in a suburbia of Kuala Lumpur City, Malaysia. Parasitol Int 60: 111-113 (ISI-Indexed)
  • Tan DB, Lim A, Yong YK, Ponnampalavanar S, Omar S, Kamarulzaman A, French M, Price P. TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS. 2011 Jul 31;25(12):1455-60 

2010
  • Adeeba Kamaruzzaman & Shaikh Mohd Saifuddeen. 2010. Islam and harm reduction. International Journal of Drug Policy 21(2): 115-118. (ISI-Indexed)
  • Sam, I., Kamarulzaman, A., Ong, G., Veriah, R. S., Ponnampalavanar, S., Chan, Y. F., & AbuBakar, S. (2010). Research note chikungunya virus-associated death in Malaysia. Tropical biomedicine, 27(2), 343-347. (ISI-Indexed)
  • Tan DBA, Yong YK, Tan HY, French M, Kamarulzaman A, et al. (2010) Characteristics of Natural Killer Cells in Malaysian HIV Patients Presenting with Immune Restoration Disease After ART. J AIDS Clinic Res 1:102 doi:10.4172/2155-6113.1000102 
  • Chew CS, Cherry CL, Imran D, Yunihastuti E, Kamarulzaman A, Varna S,Ismail R, Phipps M, Aghafar Z, Gut I, Price P. Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and caucasian human immunodeficiency virus patients. Tissue Antigens. 2010 Sep 30.doi: 10.1111/j.1399- 0039.2010.01570.x. [Epub ahead of print] PubMed PMID: 20887379 
  • Kamarulzaman A, Saifuddeen SM. Islam and harm reduction. Int J Drug Policy. 2010 Mar;21(2):115-8. Epub 2009 Dec 16. 
  • Li Y, Tee KK, Liao H, Hase S, Uenishi R, Li XJ, Tsuchiura T, Yang R, Govindasamy S, Yong YK, Tan HY, Pybus OG, Kamarulzaman A, Takebe Y. Identification of a Novel Second- Generation Circulating Recombinant Form (CRF48_01B) in Malaysia: A Descendant of the Previously Identified CRF33_01B. J Acquir Immune Defic Syndr. 2010 Apr 7. 
  • Takebe Y, Liao H, Hase S, Uenishi R, Li Y, Li XJ, Han X, Shang H, Kamarulzaman A, Yamamoto N, Pybus OG, Tee KK. Reconstructing the chronology of the expansion of HIV-1 in East Asia: the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC. Vaccine. 2010 May 26;28 Suppl 2:B39-44. 
  • CE Lee, K Adeeba, G Freigang Human Plasmodium Knolesi Infections in Klang Valley, Peninsula Malaysia : A Case Series Med J Mal Vol 65 No 1 , March 2010 
  • Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA; 2009 Reference Group to the UN on HIV and Injecting Drug Use. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010 Mar 20;375(9719):1014-28. 
  • Lau KA, Wang B, Miranda-Saksena M, Boadle R, Kamarulzaman A, Ng KP, Saksena NK. Evidence for possible biological advantages of the newly emerging HIV-1 circulating recombinant form from Malaysia - CRF33_01B in comparison to its progenitors - CRF01_AE and subtype B. Curr HIV Res. 2010 Apr 1;8(3):259-71. 
  • Oyomopito R, Lee MP, Phanuphak P, Lim PL, Ditangco R, Zhou J,Sirisanthana T, Chen YM, Kamarulzaman A, Oka S, Zhang FJ, Mean CV, Merati T, Tau G, Smith J, Li PC; on behalf of The TREAT Asia HIV Observational Databse. Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2010 Mar 21 
  • Choi P, Kavasery R, Desai MM, Govindasamy S, Kamarulzaman A, Altice FL. Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD AIDS. 2010 Jun;21 (6):416-23 
  • Tee KK, Lam TT, Chan YF, Bible JM, Kamarulzaman A, Tong CY, Takebe Y, Pybus OG. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol. 2010 Apr;84(7):3339-50. Epub 2010 Jan 20. 
  • Altice FL,Kamarulzaman A, Soriano W,Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010 Jul 31;376(9738):367-87 
  • Beyer C, Malinowska-Sempruch K, Kamarulzaman A, Strathdee SA. 12 myths about HIV/AIDS and people who use drugs. Lancet . 2010 Jul 24;376(9737):208-11 
  • Beyer C, Malinowska-Sempruch K, Kamarulzaman A, Kazatchkine M, Sidibe M, Strathdee SA. Time to Act : a call for comprehensive responses to HIV in people who use drugs.Lancet.2010Jul 20 
  • Bux SI, Mohd. Ramli N, Ahmad Sarji S, Kamarulzaman A CHEST IMAGING FEATURES OF PATIENTS AFFLICTED WITH INFLUENZA A (H1N1) IN A MALAYSIAN TERTIARY REFERRAL CENTRE Biomed Imaging Interv J 2010; 6(4):e35 (SCOPUS-Indexed)
  • Takebe, Y., Liao, H. N., Hase, S., Uenishi, R., Li, Y. E., Li, X. J., Kamarulzaman, A., Tee, K. K., et al. 2010. Reconstructing the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC in East Asia: The relevance of genetic diversity and phylodynamics for vaccine strategies Vaccine. (Tier 1, Impact Factor = 3.616) (ISI-Indexed)
  • Zhou, J. L., Sirisanthana, T., Kiertiburanakul, S., ..., Kamarulzaman, A., et al. 2010. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database Bmc Infectious Diseases. (Tier 2, Impact Factor = 2.55) (ISI-Indexed)
  • Fong, M. Y., Wong, K. T., Rohela, M., Tan, L. H., Adeeba, K., Lee, Y. Y., Lau, Y. L., et al. 2010. Unusual manifestation of cutaneous toxoplasmosis in a HIV-positive patient Tropical Biomedicine. (Tier 4, Impact Factor = 0.649) (ISI-Indexed)
  • Yue Li, BSc,Kok Keng Tee, PhD,Huanan Liao,PhD,Saiki Hase, PhD,Rie Uenishi,PhD,Xiao-Jie Li, MD, PhD,Takayo Tsuchiura, BSc,Rongge Yang, MD, PhD,Sumathi Govindasamy, BA,Yean Kong Yong, MMedSc, Hong Yien Tan, MMedSc,Oliver G. Pybus, PhD,k Adeeba Kamarulzaman,MBBS, FRACP,and Yutaka Takebe, MD, PhD.Identification of a Novel Second-Generation Circulating .Recombinant Form (CRF48_01B) in Malaysia: A Descendant of the Previously Identified CRF33_01B. Feb 2010 
  • Zahari MM, Bae WH, Zainal NZ, Habil H, Kamarulzaman A, Altice FL.Psychiatric and Substance Abuse Co-Morbidity Among HIV Seropositive and HIV Seronegative Prisoners in Malaysi. Am J Drug Alcohol Abuse.Jan;36(1);31-8 
  • Zahari, M. M., Bae, W. H., Zainal, N. Z., Habil, H., Kamarulzaman, A., Altice, F. L. 2010. Psychiatric and Substance Abuse Comorbidity among HIV Seropositive and HIV Seronegative Prisoners in Malaysia American Journal of Drug and Alcohol Abuse. (Tier 2, Impact Factor = 1.335) (ISI-Indexed)
  • Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., Friedland, G. H. 2010. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs Lancet. (Tier 1, Impact Factor = 30.758) (ISI-Indexed)
  • Ong MP, Sam IC, Azwa H, Mohd Zakaria IE, Kamarulzaman A, Wong MH, Syed Omar SF, Hussain SH. High direct healthcare costs of patients hospitalised with pandemic (H1N1) 2009 influenza in Malaysia. J Infect. 2010 Aug 11. (ISI-Indexed)

2009
  • Tee KK, Pybus OG, Parker J, Ng KP, Kamarulzaman A, Takebe Y.Estimating the date of origin of an HIV-1 circulating recombinant form.Virology. 2009 Mar 7. 
  • Cherry CL, Affandi JS, Imran D, Yunihastuti E, Smyth K, Vanar S, Kamarulzaman A, Price P. Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology. 2009 Jul 28;73(4):315-20. 
  • Srasuebkul P, Lim PL, Lee MP, Kumarasamy N, Zhou J, Sirisanthana T, Li PC, Kamarulzaman A, Oka S, Phanuphak P, Vonthanak S, Merati TP, Chen YM, Sungkanuparph S, Tau G, Zhang F, Lee CK, Ditangco R, Pujari S, Choi JY, Smith J, Law MG. Short-term clinical disease progression in HIV- infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis. 2009 Apr 1;48(7):940-50 (ISI-Indexed)
  • Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell CH, Ramos AI, Fowler V Jr, Hoen B, Kone¿ P, Moreno A, Murdoch D, Pappas P, Sexton DJ, Spelman D, Tattevin P, Mir¿ JM, van der Meer JT, Utili R; International Collaboration on Endocarditis Prospective Cohort Study Group. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med. 2008 Oct 27;168(19):2095-103 (ISI-Indexed)
  • Benito N, Mir¿ JM, de Lazzari E, Cabell CH, del R¿A, Altclas J, Commerford P, Delahaye F, Dragulescu S, Giamarellou H, Habib G, Kamarulzaman A, Kumar AS, Nacinovich FM, Suter F, Tribouilloy C, Venugopal K, Moreno A, Fowler VG Jr; ICE-PCS (International Collaboration on Endocarditis Prospective Cohort Study) Investigators. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med. 2009 May 5;150(9):586-94 (ISI-Indexed)
  • Tee, K. K., Pybus, O. G., Parker, J., Ng, K. P., Kamarulzaman, A., Takebe, Y. 2009. Estimating the date of origin of an HIV-1 circulating recombinant form Virology. (Tier 2, Impact Factor = 3.539) (ISI-Indexed)
  • Cherry, C. L., Affandi, J. S., Imran, D., Yunihastuti, E., Smyth, K., Vanar, S., Kamarulzaman, A., Price, P. 2009. Age and height predict neuropathy risk in patients with HIV prescribed stavudine Neurology. (Tier 1, Impact Factor = 7.043) (ISI-Indexed)
  • Tee, K. K., Takebe, Y., Kamarulzaman, A. 2009. Emerging and re-emerging viruses in Malaysia, 1997-2007 International Journal of Infectious Diseases. (Tier 3, Impact Factor = 2.210) (ISI-Indexed)
  • Benito, N., Miro, J. M., de Lazzari, E., ..., Kamarulzaman, A., et al. 2009. Health Care-Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition Annals of Internal Medicine. (Tier 1, Impact Factor = 17.457) (ISI-Indexed)
  • Kamarulzaman, A. 2009. Impact of HIV Prevention Programs on Drug Users in Malaysia Jaids-Journal of Acquired Immune Deficiency Syndromes. (Tier 1, Impact Factor = 4.57) (ISI-Indexed)
  • Bruce, R. D., Govindasamy, S., Sylla, L., Kamarulzaman, A., Altice, F. L. 2009. Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market American Journal of Drug and Alcohol Abuse. (Tier 3, Impact Factor = 1.094) (ISI-Indexed)
  • Egger, S., Petoumenos, K., Kamarulzaman, A., Hoy, J., Sungkanuparph, S., Chutah, J., Falster, K., Zhou, J. L., Law, M. G. 2009. Long-Term Patterns in CD4 Response Are Determined by an Interaction Between Baseline CD4 Cell Count, Viral Load, and Time: The Asia Pacific HIV Observational Database (APHOD) Jaids-Journal of Acquired Immune Deficiency Syndromes. (Tier 1, Impact Factor = 4.57) (ISI-Indexed)
  • Zhou, J. L., Elliott, J., Li, P. C. K., ..., Kamarulzaman, A., et al. 2009. Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database Bmc Infectious Diseases. (Tier 2, Impact Factor = 2.536) (ISI-Indexed)
  • Srasuebkul, P., Lim, P. L., Lee, M. P., ..., Kamarulzaman, A., et al. 2009. Short-Term Clinical Disease Progression in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Results from the TREAT Asia HIV Observational Database Clinical Infectious Diseases. (Tier 1, Impact Factor = 8.266) (ISI-Indexed)
  • Kamarulzaman A, Impact of HIV Prevention Programs on Drug Users in Malaysia . J Acquir Immune Defic Syndr .Nov;52 Suppl 1;S17-9 
  • Kamarulzaman A, Antiretroviral therapy in Malaysia; identifying barriers to universal access HIV Therapy. Nov , Vol. 3, No. 6, Pages 573-582 
  • Tee KK, Kusagawa S, Li XJ, Onogi N, Isogai M, Hase S, Uenishi R, Liao H, Kamarulzaman A, Takebe Y. Isolation and characterization of a replication- competent molecular clone of an HIV-1 circulating recombinant form (CRF33_01B)PLoS One. Aug 18;4 (8). 
  • Tee KK, Takebe Y, Kamarulzaman A. Emerging and re- emerging viruses in Malaysia, 1997-2007. Int J Infect Dis. 2009 May;13(3):307-18. 

2008
  • Tan DB, Yong YK, Tan HY, Kamarulzaman A, Tan LH, Lim A, James I, French M, Price P. Immunological Profiles of Immune Restoration Disease Presenting as Mycobacterial Lymphadenitis and Cryptococcal Meningitis. HIV Med. 2008 May;9(5):307-16 
  • Tee KK, Takebe Y, Kamarulzaman A. Emerging and re-emerging viruses in Malaysia, 1997-2007. Int J Infect Dis. 2008 Nov 13 
  • Bruce RD, Govindasamy S, Sylla L, Haddad MS, Kamarulzaman A, Altics FL. Case Series of Buprenorphine Injectors in Kuala Lumpur, Malaysia. AM J Drug Alcohol Abuse. 2008;24(4):511-7 
  • Wright E, Brew B, Arayawichanont A, Robertson k, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffman S, Li P, Imran D, Lewis J, Lun WH, Kamarulzaman A, Tau G, Ali ST, Kishore K, Bain MP, dwyer R, McCormack G, Hellard M, Cherry C, Mc Arthur J, Wesselingh S. Neurologic Disorders are Prevalent in HIV-posotive Outpatients in the Asia-Pacific Region. Neurology. 2008 Jul 1;71(1):50-6. 
  • Tee KK, Pybus OG, Li XJ, Han X, Shang H, Kamarulzaman A, Takebe Y. Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia. J Virol. 2008 Sep;82(18):9206-15. 
  • Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP; 2007 Reference Group to the UN on HIV and Injecting Drug Use. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008 Nov 15;372(9651):1733-45 
  • Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell CH, Ramos AI, Fowler V Jr, Hoen B, Kamarulzaman A, Konecny P, Moreno A, Murdoch D, Pappas P, Sexton DJ, Spelman D, Tattevin P, Miro JM, van der Meer JT, Utili R; International Collaboration on Endocarditis Prospective Cohort Study Group. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study Arch Intern Med. 2008 Oct 27; 168(19):2095-103 
  • Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Near full-length sequence analysis of a Unique CRF01_AE/B recombinant from Kuala Lumpur, Malaysia. AIDS Res Hum Retroviruses. 2007 Sep;23(9):1139-45. 
  • 33. Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16 
  • Tee, K. K., Pybus, O. G., Liao, H., Uenishi, R., Hase, S., Kamarulzaman, A., et al. 2008. Chronology of the HIV-1CRF07_BC expansion in East Asia Aids. (Tier 1, Impact Factor = 5.842) (ISI-Indexed)
  • Tee KK, Pybus OG, Liao H, Uenishi R, Hase S, Kamarulzaman A, Li XJ, Takebe Y.Chronology of the HIV- 1 CRF07_BC expansion in East Asia. AIDS. 2008 Jan 2;22(1):156-8. 
  • Baddley JW, Benjamin DK Jr, Patel M, Mir J, Athan E, Barsic B, Bouza E,Clara L, Elliott T, Kanafani Z, Klein J, Lerakis S, Levine D, Spelman D,Rubinstein E, Tornos P, Morris AJ, Pappas P, Fowler VG Jr, Chu VH, Cabell C; International Collaboration on Endocarditis- Prospective Cohort Study Group (ICE - PCS).Eur J Clin Microbiol Infect . Candida infective endocarditis. Dis. 2008 Jul;27(7):519-29. 
  • Baskaran, N. D., Gan, G. G., Adeeba, K. 2008. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients Annals of Hematology. (Tier 2, Impact Factor = 2.342) (ISI-Indexed)
  • Bruce, R. D., Govindasamy, S., Sylla, L., Haddad, M. S., Kamarulzaman, A., Altice, F. L. 2008. Case series of buprenorphine injectors in Kuala Lumpur, Malaysia American Journal of Drug and Alcohol Abuse. (Tier 2, Impact Factor = 1.236) (ISI-Indexed)
  • Sherman, S. G., Kamarulzaman, A., Spittal, P. 2008. Women and drugs across the globe: A call to action International Journal of Drug Policy. (Tier 2, Impact Factor = 1.272) (ISI-Indexed)
  • Tee, K. K., Pybus, O. G., Li, X. J., Han, X. X., Shang, H., Kamarulzaman, A., et al. 2008. Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia Journal of Virology. (Tier 1, Impact Factor = 5.332) (ISI-Indexed)
  • Wright, E., Brew, B., Arayawichanont, A., Robertson, K., Samintharapanya, K., Kongsaengdao, S., et al. 2008. Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region Neurology. (Tier 1, Impact Factor = 6.014) (ISI-Indexed)
  • Tan, D., Yong, Y., Tan, H., Kamarulzaman, A., Tan, L., Lim, A., et al. 2008. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis Hiv Medicine. (Tier 1, Impact Factor = 3.347) (ISI-Indexed)
  • Lau, K. A., Wang, B., Kamarulzaman, A., Ng, K. P., Saksena, N. K. 2008. Continuous crossover(s) events of HIV-1CRF01_AE and B subtype strains in Malaysia: Evidence of rapid and extensive HIV-1 evolution in the region Current Hiv Research. (Tier 2, Impact Factor = 2.653) (ISI-Indexed)
  • Sherman SG, Kamarulzaman A, Spittal P.Women and drugs across the globe: a call to action. Int J Drug Policy. 2008 Apr;19(2):97-8. 
  • Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16 

2007
  • Todd CS, Nassiramanesh B, Stanekzai MR, Kamarulzaman A. Emerging HIV Epidemics in Muslim Countries: Assessment of Different Cultural Responses to Harm Reduction and Implications for HIV Control. Cur HIV/AIDS Rep. 2007 Dec;4(4):151-7 
  • Sylla L, Bruce RD, Kamarulzaman A, Altice FL. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy. 2007 Aug;18(4):306-12 
  • Reid G, Kamarulzaman A, Sran SK. Malaysia and harm reduction: the challenges and responses. Int J Drug Policy. 2007 Mar;18(2):136-40 
  • Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, James I, French MA. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS. 2007 Jul 31;21(12):1525-34. 
  • Lau, K. A., Wang, B., Kamarulzaman, A., Ng, K. P., Saksena, N. K. 2007. Near full-length sequence analysis of a unique CRF01_AE/B recombinant from Kuala Lumpur, Malaysia Aids Research and Human Retroviruses (ISI-Indexed)
  • Reid, G., Kamarulzaman, A., Sran, S. K. 2007. Malaysia and harm reduction: The challenges and responses International Journal of Drug Policy (ISI-Indexed)
  • Zhou, J., Paton, N. I., Ditangco, R., Chen, Y. M., Kamarulzaman, A., Kumarasamy, N., Lee, C. K. C., Li, P. C. K., Merati, T. P., Phanuphak, P., Pujari, S., Vibhagool, A., Zhang, F., Chuah, J., Frost, K. R., Cooper, D. A., Law, M. G. 2007. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database Hiv Medicine (ISI-Indexed)
  • Wang B, Lau KA, Ong LY, Shah M, Steain MC, Foley B, Dwyer DE, Chew CB, Kamarulzaman A, Ng KP, Saksena NK. Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: Evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants. Virology. 2007 Oct 25;367(2):288-97. 
  • Zhou J, Paton NI, Ditangco R, Chen YM, Kamarulzaman A, Kumarasamy N, Lee CK, Li PC, Merati TP, Phanuphak P, Pujari S, Vibhagool A, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database. HIV Med. 2007 Jan;8(1):8-16. 
  • Wang, B., Lau, K. A., Ong, L. Y., Shah, M., Steam, M. C., Foley, B., Dwyer, D. E., Chew, C. B., Kamarulzaman, A., Ng, K. P., Saksena, N. K. 2007. Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: Evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants Virology (ISI-Indexed)
  • Baskaran, N. D., Gan, G. G., Adeeba, K., Sam, I. C. 2007. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia International Journal of Infectious Diseases (ISI-Indexed)
  • Lim, A., Tan, D., Price, P., Kamarulzaman, A., Tan, H. Y., James, I., French, M. A. 2007. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy Aids (ISI-Indexed)

2006
  • Tee KK, Kamarulzaman A, Ng KP. Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia. Med Microbiol Immunol. 2006 Jun;195(2):107-12. 
  • Tee KK, Kamarulzaman A, Ng KP. Short communication: low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia. AIDS Res Hum Retroviruses. 2006 Feb;22(2):121-4. 
  • Tee KK, Li XJ, Nohtomi K, Ng KP, Kamarulzaman A, Takebe Y. Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia. J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):523-9. 
  • Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16 
  • Raja NS, Parasakthi N, Puthucheary SD, Kamarulzaman A. Invasive meningococcal disease in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia. J Postgrad Med. 2006 Jan-Mar;52(1):23-9; 
  • Tee, K. K., Kamarulzaman, A., Ng, K. P. 2006. Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia Medical Microbiology and Immunology (ISI-Indexed)
  • Zhou, M. L., Phanupak, P., Kiertiburanakul, S., Ditangco, R., Kamarulzaman, A., Pujary, S., et al. 2006. Highly active antiretroviral treatment containing efavirenz or nevirapine and related toxicity in the TREAT Asia HIV Observational Database Jaids-Journal of Acquired Immune Deficiency Syndromes (ISI-Indexed)
  • Tee, K. K., Li, X. J., Nohtomi, K., Ng, K. P., Kamarulzaman, A., Takebe, Y. 2006. Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia Jaids-Journal of Acquired Immune Deficiency Syndromes (ISI-Indexed)
  • Raja, N. S., Parasakthi, N., Puthucheary, S. D., Kamarulzaman, A. 2006. Invasive meningococcal disease in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia Journal of Postgraduate Medicine (ISI-Indexed)
  • Tee, K. K., Kamarulzaman, A., Ng, K. P. 2006. Low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia Aids Research and Human Retroviruses (ISI-Indexed)

2005
  • Tee KK, Saw TL, Pon CK, Kamarulzaman A, Ng KP. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. AIDS Res Hum Retroviruses. 2005 Dec;21(12):1046-50. 
  • Nurul Atifah MA, Loo HK, Subramaniam G, Wong EH, Selvi P, Ho SE, Kamarulzaman A, Parasakthi N. Faecal prevalence of extended-spectrum Beta-lactamase (ESBL)-producing coliforms in a geriatric population and among haematology patients. Malays J Pathol. 2005 Dec;27(2):75-81. 
  • Hughes AJ, Ariffin N, Huat TL, Abdul Molok H, Hashim S, Sarijo J, Abd Latif NH, Abu Hanifah Y, Kamarulzaman A. Prevalence of nosocomial infection and antibiotic use at a university medical center in Malaysia. Infect Control Hosp Epidemiol. 2005 Jan;26(1):100-4. 
  • Joazlina ZY, Wastie ML, Kamarulzaman A. Kostmann\'s syndrome. Clin Imaging. 2005 Sep-Oct;29(5):364-6. 
  • Zhou J, Kumarasamy N, Ditangco R, Kamarulzaman A, Lee CK, Li PC, Paton NI, Phanuphak P, Pujari S, Vibhagool A, Wong WW, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG, The TREAT Asia HIV Observational Database: Baseline and Retrospective Data, 2005, J. Acquir. Immune Defic. Syndr., Vol. 138, no. 2, pg. 174-179 
  • Ranganathan S, Moosa F, Kamarulzaman A, Looi LM. MRI and CT findings of cryptococcal vaginitis. 2005, Br. J. Radiol., Vol. 78, no. 928, pg. 353-354 
  • Adeeba Kamarulzaman .Taking stock of two decades of the HIV/AIDS epidemic in Malaysia. 2005, Med. J. Malaysia, Vol. 60, no. 1, pg. 1-4 
  • Tee KK, Pon CK, Kamarulzaman A, Ng KP. Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia. AIDS. 2005 Jan 28;19(2):119-26. 
  • Tee KK, Saw TL, Pon CK, Kamarulzaman A, Ng KP. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. AIDS Res Hum Retroviruses. 2005 Dec;21(12):1046-50. 
  • Joazlina, Z. Y., Wastie, M. L., Kamarulzaman, A. 2005. Kostmanns syndrome Clinical Imaging (ISI-Indexed)
  • Tee, K. K., Pon, C. K., Kamarulzaman, A., Ng, K. P. 2005. Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia Aids (ISI-Indexed)
  • Ranganathan, S., Moosa, F., Kamarulzaman, A., Looi, L. M. 2005. MRI and CT findings of cryptococcal vaginitis British Journal of Radiology (ISI-Indexed)
  • Zhou, J., Kumarasamy, N., Ditangco, R., Kamarulzaman, A., Lee, C. K. C., Li, P. C. K., et al. 2005. The TREAT Asia HIV observational database - Baseline and retrospective data Jaids-Journal of Acquired Immune Deficiency Syndromes (ISI-Indexed)
  • Tee, K. K., Saw, T. L., Pon, C. K., Kamarulzaman, A., Ng, K. P. 2005. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia Aids Research and Human Retroviruses (ISI-Indexed)
  • Vinothini. A, Khoo, E.M. & Adeeba, K. 2005. Knowledge of HIV/AIDs in among pregnant women in an urban health clinic - a preliminary study. The Family Physician 13(1&2): 10-15 (Non-ISI/Non-SCOPUS)

2004
  • Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, Ki HK, Oh WS, Suh JY, Peck KR, Lee NY, Yang Y, Lu Q, Chongthaleong A, Chiu CH, Lalitha MK, Perera J, Yee TT, Kumarasinghe G, Jamal F, Kamarulzaman A, Parasakthi N, Van PH, Carlos C, So T, Ng TK, Shibl A. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother. 2004 Jun;48(6):2101-7. 
  • Oh WS, Suh JY, Song JH, Ko KS, Jung SI, Peck KR, Lee NY, Yang Y, Chongthaleong A, Chiu CH, Kamarulzaman A, Parasakthi N, Lalitha MK, Perera J, Yee TT, Kumarasinghe G, Carlos CC; ANSORP Study Group. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study. Microb Drug Resist. 2004 Spring;10(1):37-42 
  • Song JH, Jung SI, Ki HK, Shin MH, Ko KS, Son JS, Chang HH, Kim SW, Lee H, Kim YS, Oh WS, Peck KR, Chongthaleong A, Lalitha MK, Perera J, Yee TT, Jamal F, Kamarulzaman A, Carlos CC, So T; Asian Network for Surveillance of Resistant Pathogens Study Group. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Clin Infect Dis. 2004 Jun 1;38(11):1570-8 
  • Kamarulzaman A. Tackling infectious diseases threats in the Asia-Pacific through regional and international collaboration. Asia Pac J Public Healt. 2004;16(1):1-2 

2002
  • Tan YM, Goh KL, Kamarulzaman A, Tan PS, Ranjeev P, Salem O, Vasudevan AE, Rosaida MS, Rosmawati M, Tan LH. Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate. Gastrointest Endosc. 2002 Feb;55(2):276-8. 
  • Gan GG, Kamarulzaman A, Goh KY, Ng KP, Na SL, Soo-Hoo TS. Non-sporulating Chrysosporium: an opportunistic fungal infection in a neutropenic patient. Med J Malaysia. 2002 Mar;57(1):118-22. 
  • Tan LH, Kamarulzaman A, Liam CK, Lee TC. Tuberculin skin testing among healthcare workers in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia. Infect Control Hosp Epidemiol. 2002 Oct;23(10):584-90. 
  • Nissapatorn V, Kamarulzaman A, Init I, Tan LH, Rohela M, Norliza A, Chan LL, Latt HM, Anuar AK, Quek KF. Seroepidemiology of toxoplasmosis among HIV-infected patients and healthy blood donors. Med J Malaysia. 2002 Sep;57(3):304-10. 
  • Tan, Y. M., Goh, K. L., Kamarulzaman, A., Tan, P. S., Ranjeev, P., Salem, O., et al. 2002. Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate Gastrointestinal Endoscopy (ISI-Indexed)
  • Tan, L. H., Kamarulzaman, A., Liam, C. K., Lee, T. C. 2002. Tuberculin skin testing among healthcare workers in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia Infection Control and Hospital Epidemiology (ISI-Indexed)

2001
  • Chua KB, Lam SK, Goh KJ, Hooi PS, Ksiazek TG, Kamarulzaman A, Olson J, Tan CT. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. J Infect. 2001 Jan;42(1):40-3. 
  • Chong HT, Kamarulzaman A, Tan CT, Goh KJ, Thayaparan T, Kunjapan SR, Chew NK, Chua KB, Lam SK. Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol. 2001 Jun;49(6):810-3. 
  • Chua, K. B., Lam, S. K., Goh, K. J., Hooi, P. S., Ksiazek, T. G., Kamarulzaman, A., Olson, J., Tan, C. T. 2001. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia Journal of Infection (ISI-Indexed)
  • Chong, H. T., Kamarulzaman, A., Tan, C. T., Goh, K. J., Thayaparan, T., Kunjapan, R., Chew, N. K., Chua, K. B., Lam, S. K. 2001. Treatment of acute Nipah encephalitis with ribavirin Annals of Neurology (ISI-Indexed)

2000
  • Chua KB, Lam SK, Tan CT, Hooi PS, Goh KJ, Chew NK, Tan KS, Kamarulzaman A, Wong KT. High mortality in Nipah encephalitis is associated with presence of virus in cerebrospinal fluid. Ann Neurol. 2000 Nov;48(5):802-5. 
  • Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sarji SA, Wong KT, Abdullah BJ, Chua KB, Lam SK. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 2000 Apr 27;342(17):1229-35. 
  • Tan SY, Tan LH, Teo SM, Thiruventhiran T, Kamarulzaman A, Hoh HB. Disseminated nocardiosis with bilateral intraocular involvement in a renal allograft patient. Transplant Proc. 2000 Nov;32(7):1965-6. 
  • Goh, K. J., Tan, C. T., Chew, N. K., Tan, P. S. K., Kamarulzaman, A., Sarji, S. A., et al. 2000. Clinical features of nipah virus encephalitis among pig farmers in Malaysia New England Journal of Medicine (ISI-Indexed)

1999
  • Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek TG, Zaki SR, Paul G, Lam SK, Tan CT. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet. 1999 Oct 9;354(9186):1257-9 
  • Pakianathan, M. R., Kamarulzaman, A., Ismail, R., McMillan, A., Scott, G. R. 1999. Hypersensitivity reactions to high-dose co-trimoxazole in HIV-infected Malaysian and Scottish patients Aids (ISI-Indexed)
  • Chua, K. B., Goh, K. J., Wong, K. T., Kamarulzaman, A., Tan, P. S. K., Ksiazek, T. G., et al. 1999. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia Lancet (ISI-Indexed)
  • Pakianathan MR, Kamarulzaman A, Ismail R, McMillan A, Scott GR. Hypersensitivity reactions to high-dose co-trimoxazole in HIV-infected Malaysian and Scottish patients. AIDS. 1999 Sep 10;13(13):1787-8. No abstract available 

1996
  • Kamarulzaman A, Briggs RJ, Fabinyi G, Richards MJ. Skull osteomyelitis due to Salmonella species: two case reports and review. Clin Infect Dis. 1996 Apr;22(4):638-41. 
Mass Media(Newspaper,Radio,Tv,Popular Magazine)

2015
  • Her World Power list: 6 most inspiring women of Singapore and Malaysia 
  • Malay Mail - Monash Honarary Doctorate Award 
  • Rawatan penagih lebih baik di luar penjara 

2014
  • Metro Ahad / Karisma 

2013
  • Adeeba Kamarulzaman and Bertrand Union . Winds of change on drug policy 
  • Adeeba Kamarulzaman. Penghidap HIV turun 
  • The female face of HIV/AIDS 
  • FRONTLINER FOR HIV AIDS PROFESSOR DR ADEEBA KAMARULZAMAN ON THE CAUSE CLOSE TO HER HEART 
  • THE THIN RED LINE 
  • Foundation receives RM25,000 - NST 
  • AN EVENING OF GLAMOUR AND GOODWILL THE MALAYSIAN AIDS COUNCIL ANNUAL 
  • Adeeba Kamarulzaman,Reena Rajasuriar 

2012
  • New York Times : Towards an AIDS-Free World 
Others

1999
  • A Kamarulzaman, KJ Goh. Causes of viral encephalitis outbreaks in Malaysia and Australia. In UptoDate. Eds JG Bartlett, SB Calderwood, MS Hirsch, et al. 1999 

AREAS OF RESEARCH
(Project title), (Role), (From)-(Until), (Level), (Source).


  • Tabung Rmf Individu - Adeeba Kamarulzaman, Principal Investigator(PI), 2019 - 2020, KW IPPP - Research Maintenance Fee (RMF) Individual/Centre/Group, (National)
  • Studies On Association Of Metabolism Dysfunction And Immune Exhaustion Of Exhausted Hiv-specific Cd8+ T-cell Phenotype In Hiv Infected Individuals, Principal Investigator(PI), 2019 - 2022, Fundamental Research Grant Scheme (FRGS), (National)
  • Developing An International Master's Of Research Ethics Program In Malaysia, Principal Investigator(PI), 2018 - 2023, International Funding, (International)
  • Tuberculosis Treatment Programme In Prisons And Barriers To Continuity Of Tb Treatment After Release To The Community In Malaysia : A Health System Evaluation, Principal Investigator(PI), 2017 - 2018, International Funding, (International)
  • Addiction, Hiv And Tuberculosis In Malaysian Criminal Justice Settings, Principal Investigator(PI), 2016 - 2021, International Funding, (International)
  • Survey of factors associated with intent to discriminate against people live with HIV/AIDS amongst healthcare providers, Principal Investigator(PI), 2016 - 2017, Postgraduate Research Grant (PPP) - Course & Disertation, (National)
  • Review Of Policy Towards Healthy Lifestyles, Consultant, 2015 - 2017, RU Operation, (National)
  • Research Management Fee Centre Of Excellence For Research In Aids (ceria), Principal Investigator(PI), 2015 - 2021, KW IPPP, (National)
  • The relationship between lipodystrophy, insulin resistance, adiponectin levels and their association with subclinical atherosclerosis in aging HIV patients compared to the non HIV population., Consultant, 2015 - 2017, Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science), (University)
  • Impact Of Tuberculosis Co-infection On Immunological And Virological Outcomes Among Hiv Infected Patients, Principal Investigator(PI), 2014 - 2018, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness), (University)
  • The Impact Of The Changing Genotypic And Phenpotypic Trends Of Methicillin-resistant Staphylococcus Aureus (mrsa) Infection In A Tertiary Teaching Hospital- A 5 Year Cohort Study, Consultant, 2014 - 2018, Fundamental Research Grant Scheme (FRGS), (National)
  • Free circulating mitochondrial DNA and its association with tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS), Consultant, 2014 - 2015, Research Officer Grant Scheme (ROGS), (National)
  • Adult Dengue Platelet Study (ADEPT), Co-Investigator, 2013 - 2015, National Medical Research Council (NMRC) Singapore, (National)
  • Mitigating The Malaysian Hiv Epidemic Through A Comprehensive Research Programme (2)., Principal Investigator(PI), 2013 - 2017, High Impact Research - Ministry of Education (HIR-MOE) Cycle 3, (National)
  • Mitigating The Malaysian Hiv Epidemic Through A Comprehensive Research Programme (3)., Principal Investigator(PI), 2013 - 2018, High Impact Research - Ministry of Education (HIR-MOE) Cycle 3, (National)
  • Optimization Of Biochemical And Functional Interaction Between Hiv-1 Tat Protein And Rna Aptamer, Principal Investigator(PI), 2013 - 2016, Program Rakan Penyelidikan - RACE, (National)
  • Demographic Network Modelling Of The Spread Of Infectious Diseases, Consultant, 2013 - 2017, Geran Penyelidikan Universiti Malaya (UMRG Programme) - SBS (Equitable Society), (University)
  • IMPLEMENTATION SCIENCE RESEARCH WITH ONLINE DATA DEPOSITORY AT KERINCHI AND KUANTAN, Principal Investigator(PI), 2013 - 2015, Government Agency, (National)
  • A Novel Community Healthcare Service Delivery Model For Fishermen Who Use Drugs In Kuantan, Pahang: An Implentation Science Research, Principal Investigator(PI), 2013 - 2014, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness), (University)
  • Geran Sanjungan Penyelidikan- Mo002-2013, Principal Investigator(PI), 2013 - 2017, Others MOHE, (National)
  • Evaluation of an Antimicrobial Stewardship Programme in improving the use of antibiotics and outcomes of surgical patients in a tertiary hospital in Malaysia, Consultant, 2012 - 2014, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • Investigations On Regulatory Molecules In T Cells Of Antiretroviral Therapy (art) Naive And Treated Hiv-1 Infected Individuals, Consultant, 2012 - 2014, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • Molecular Genetics of Respiratory Pathogens Associated with Respiratory Tract Infections (From January 2012) High Impact Research (HIR): Genetics of the Respiratory, Gastrointestinal, Central Nervous System and Blood-borne Pathogens, Co-Investigator, 2012 - 2014, High Impact Research (HIR), (University)
  • Strengthening Epidemic Intelligence in Malaysia, Principal Investigator(PI), 2011 - 2011, , (University)
  • Diseases among poverty (A community based participatory action research project), Co-Investigator, 2011 - 2012, HTMC, Flag ship, (University)
  • Mitigating The Malaysian Hiv Epidemic Through A Comprehensive Research Programme (ceria)., Principal Investigator(PI), 2011 - 2016, High Impact Research - Ministry of Education (HIR-MOE) Cycle 1, (National)
  • A Multicentre Study To Validate The Predictive Value Of Warning Signs In Dengue, Co-Investigator, 2011 - 2011, WHO, (National)
  • ASSESMENT OF THE CURE AND CARE 1MALAYSIA CLINICS FOR DRUG USE AND MEDICALLY-RELATED SERVICES, Principal Investigator(PI), 2011 - 2019, Government Agency, (National)
  • A phase 2B multicenter, randomized, comparative trial of UK-453.061 versus etravirine in combination with Darunavir/Ritonavir and a Nucleotide/Nucleoside reverse transcriptase inhibitor for the treatment of antiretroviral experienced HIV-1 infected subjects with evidence of NNRTI 0resistant HIV-1. A phase 2B/3 open-label rollover study for subjects discontinuing from the UK-453,061 protocols for the treatment of HIV-1 infected subjects. Sponsor : Pfizer, Principal Investigator(PI), 2010 - 2012, Pfizer, (National)
  • HIV LATENT-INFECTION OF NEUTROPHILS :RELATION TO THEIR FUNCTIONAL ACTIVITY, Principal Investigator(PI), 2010 - 2013, Fundamental Research Grant Scheme (FRGS), (National)
  • CERIA - OPEX & CAPEX, Principal Investigator(PI), 2010 - 2010, Centre of Research , (National)
  • CENTRE OF EXCELLENCE FOR RESEARCH IN AIDS (CERIA)-OPEX & CAPEX, Principal Investigator(PI), 2010 - 2011, Centre of Research , (National)
  • HIV RESEARCH, Principal Investigator(PI), 2009 - 2010, Centre of Research , (National)
  • SOCIAL DETERMINANTS AND EPIDEMIOLOGICAL ROUTES OF HIV/STI/ HEPATITIS C TRANSMISSION AMONG FISHERMAN IN KUANTAN, Principal Investigator(PI), 2009 - 2011, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • A prospective observational cohort study of immune reconstitution and its consequences in immunodeficient HIV-infected patients treated with highly active anti-retroviral therapy., Co-Investigator, 2009 - 2011, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Social Determinants Epidemiological Routes of HIV/STI transmission Among Fishermen, Principal Investigator(PI), 2009 - 2011, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Intervention Of Hiv, Drug And The Criminal Justice System In Malaysia (project Harapan), Principal Investigator(PI), 2009 - 2017, International Funding, (International)
  • International Collaboration on Endocarditis (ICE) Prospective Cohort Study of Infective Endocarditis, Co-Investigator, 2008 - 2008, ICE, (International)
  • A randomized, open label, comparative multicenter study of voriconazole versus conventional amphotericin B followed by fluconazole in the treatment of candidaemia in non neutropaenic subjects, Co-Investigator, 2008 - 2008, PFIZER Inc, (International)
  • ZEPHYR study, Principal Investigator(PI), 2008 - 2008, Pharmaceutical company (Pfizer), (International)
  • An open non-comparative, multicentre study to assess the efficacy and safety of oral SB 265805 320 mg once daily for 7 days for the treatment of lower respiratory tract infections in adults. Sponsor: Smith-Kline Beecham International, Co-Investigator, 2008 - 2008, Smith-Kline Beecham International, (International)
  • Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia Sponsor: National Institutes on Drug Abuse, USA, Principal Investigator(PI), 2008 - 2008, National Institutes on Drug Abuse, USA, (International)
  • HIV RESEARCH, Principal Investigator(PI), 2008 - 2009, Centre of Research , (National)
  • A Randomised Open-Label Study Comparing the Safety and Efficacy of Three Different Combinations Antiretroviral Regimens as Initial Therapy for HIV Infection. The Altair Study, Co-Investigator, 2008 - 2008, NCHECR, University of New South Wales , (National)
  • Pilot Project: Introducing Methadone and HAART for Soon To Be Released HIV-Positive Prisoners in Pengkalan Chepa Kelantan, Co-Investigator, 2008 - 2008, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Genotypic and Phenotypic Characterization of Novel Human Immunodeficiency Virus Type 1 (HIV-1) Circulating Recombinant Form (CRF33_01B) in Malaysia, Principal Investigator(PI), 2007 - 2008, ScienceFund, (National)
  • A randomised Open-Label Study Comparing the Safety and Efficacy of Three Different Conmbinations Antiretroviral Regimens as Initial Therapy for HIV Infection. The Altair Study, Principal Investigator(PI), 2006 - 2012, NCHECR, University of New South Wales, (National)
  • Monitoring and Evaluation of HIV Drug Resistance in Patients on Antiretroviral Therapy. TREAT Asia Studies to Evaluate Resistance (TASER) Protocol: TASER M., Co-Investigator, 2006 - 2008, TREAT Asia, (National)
  • Evaluation of Transmitted HIV Drug Resistance in Treatment Na ve, Recently Infected HIV Individuals. TREAT Asia Studies to Evaluate Resistance (TASER) Protocol: TASER S, Co-Investigator, 2006 - 2008, TREAT Asia, (National)
  • A randomized, controlled, open label-label trial to compare the efficacy, safety and tolerability of TMC114/RTV versus LPV/RTV in treatment- experienced HIV-infected subjects Protocol: TMC114-214, Co-Investigator, 2005 - 2008, Tibotec, (National)
  • International collaborative study on epidemiological survey of HIV infections, isolation and characterisation of unique HIV-1 recombinants emerging in Malaysia., Principal Investigator(PI), 2005 - 2008, Japan Foundation for AIDS Prevention, (National)
  • Immune Reconstitution Disease in Severely Immuno- deficient AIDS patients commencing HAART Collaborator: University of Western Australia, Principal Investigator(PI), 2004 - 2008, University of Western Australia, (National)
  • Linezolid In The Treatment of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus Protocol: A5951001, Consultant, 2004 - 2008, Pfizer, (National)
  • A prospective randomized, double-blind, placebo- controlled, dose ranging, multi-center study of the safety and efficacy of three days continuous intravenous infusion of GR270773 in the treatment of suspected or confirmed gram negative severe sepsis in adults, Co-Investigator, 2004 - 2008, GSK, (National)
  • TREAT Asia Observational Database, Co-Investigator, 2003 - 2008, amfAR, (National)
  • A Multi-faceted Study of HIV in Malaysia CIPRA R03 AI 56379-01, Principal Investigator(PI), 2003 - 2008, National Institute of Health, USA, (National)
  • LY333328 versus vancomycin in complicated skin/skin-structure infections. Protocol H4Q-MC-ARRI, Co-Investigator, 2001 - 2008, Eli - Lily, (National)
  • A cross sectional survey and prospective study on tuberculin skin reaction among healthcare workers at University Malaya Medical Centre, Co-Investigator, 2001 - 2008, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • A Phase 111 study comparing the antiviral efficacy and safety of BMS-232632 with efavirenz, each in combination with fixed dose zidovudine-lamivudine, Co-Investigator, 2000 - 2008, Bristol-Myers Squibb, (National)
  • Clinical impact of antimicrobial resistance among invasive pneumococcal pathogens in Asian countries, Co-Investigator, 2000 - 2008, ANSORP, (National)
  • Prophylactic versus pre-emptive therapy of cytomegalovirus infection in bone marrow and solid organ transplant patients, Principal Investigator(PI), 1999 - 2008, IRPA, (National)
  • Efficacy and Safety of Oral Gatifloxacin versus oral amoxacillin with a treatment duration of 7 to 10 days in patients with bacterial community acquired pneumonia, Co-Investigator, 1999 - 2008, Grunenthal Gmbh, (National)
  • A Phase 1B Study to Evaluate the Safety, Pharmacokinetics, and Effects of (+)-Calanolide A on Surrogate Markers in HIV Positive Patients with No Previous Antiretroviral Therapy, Co-Investigator, 1999 - 2008, Sarawak Medichem Pharmaceuticals, (National)

CONSULTATION PROJECT/CONSULTANCY
(Project title), (Role), (From)-(Until), (Organisation).


  • WHO 2013 Consolidated guidelines on the use of antiretroviral for the treatment and prevention of HIV, Temporary Advisor, 2013-2013, WHO
  • Consultation on Ethics in Conducting Research in People Who Use Drugs- UNAIDS. Istanbul, Consultant, 2010-2010, UNAIDS
  • Consultation on Ethics in Conducting Research in People Who Use Drugs 2 - UNAIDS, WHO. Kuala Lumpur , December 2010, 2010-2010, WHO
  • Confronting HIV among people who Inject Drugs - Kuala Lumpur Dec 09, Consultant, 2009-2009, Meeting on the Development of the Regional Strategy for Harm Reduction in Asia and the Pacific 2010-2015
  • Meeting on the Development of the Regional Strategy for Harm Reduction in Asia and the Pacific 2010-2015 Confronting HIV Among People Who Inject Drugs Kuala Lumpur, Consultant, 2009-2009, -
  • Global Advocacy for Injecting Drug Use Bill and Melinda Gates Foundation, London, Consultant, 2008-2008, Bill and Melinda Gates Foundation
  • World Health Organisation. HIV Testing and Counselling. Phnom Penh, Consultant, 2007-2007, World Health Organisation
  • World Health Organisation. HIV Testing and Counselling in IDU. Manila, Consultant, 2007-2007, World Health Organisation
  • Institute of Medicine, National Academies of Sciences, USA. Prevention of HIV Infection among Injecting Drug Users in High Risk Countries An Assessment of the Evidence., Consultant, 2005-2005, Institute of Medicine, National Academies of Sciences, USA
  • Antibiotics prescribing practices of upper respiratory tract infections in primary care, Clinical Consultant, 2003-2003, MOSTI
  • ASEAN Workshop for the Exchange of Information on Increasing Access to HIV/AIDS Drug, Representative, 2002-2002, APCASO
  • ASEAN Workshop for the Exchange of Experience on Increasing Access to Treatment and Care for PLWHA, Representative, 2002-2002, APCASO
  • ASEAN Workshop for the Exchange of Information on Increasing Access to HIV/AIDS Drug, Representative, 2002-2002, ASEAN
  • United Nations General Assembly Special Session on HIV/AIDS, Member, 2001-2001, United Nations
  • Special Session on HIV/AIDS. New York., Member, 2001-2001, United Nations General Assembly
  • ASEAN Forum on HIV/AIDS. Port Dickson., Consultant, 2001-2001, Ministry of Health Malaysia
  • UK Department for International Development HIV-AIDS Project. Towards a Strategy for Commonwealth Universities Geneva., Consultant, 2001-2001, Association of Commonwealth Universities
  • Visiting Consultant Physician, Clinical Consultant, 2000-2002, Institut Jantung Negara
  • Workshop on Notifiable Diseases., Consultant, 2000-2000, Ministry of Health Malaysia
  • WHO Global Strategy for Containment of Antimicrobial Resistance Geneva., Consultant, 2000-2000, World Health Organisation

AWARDS AND RECOGNITIONS
(Name of Award), (Awarding Institution), (Year Awarded), (Level).


  • Sijil Penghargaan Kepada Panel Pakar Penasihat Pihak Berkuasa Kawalan Dadah, Pihak Berkuasa Kawalan Dadah, Kkm, 2019, (National)
  • President-Elect , International Aids Society, 2018, (International)
  • Certificate of Appreciation, Perdana University, 2018, (National)
  • University Malaya, University Malaya, 2017, (University)
  • , Sultan Perak, 2016, (State)
  • Honarary Doctorates, Monash University, 2015, (International)
  • Certificate of Excellent Service, University Malaya, 2014, (University)
  • Top Research Scientists Malaysia, Akademi Sains Malaysia, 2014, (National)
  • Certificate of Credentialing & Privileging, University Malaya, 2013, (University)
  • Um Excellence Award, Naib Canselor, 2012, (University)
  • Sijil Penghargaan - Jawatankuasa Majlis Penilaian Teknologi Kesihatan Dan Panduan Amalan Klinikal, Kementerian Kesihatan Malaysia, 2012, (National)
  • Anugerah Cermerlang Universiti Malaya 2012, University Malaya, 2012, (University)
  • Australian Education Achievement Award 2012 ( Winner - Alumni Category ), Australian High Commissioner, Kuala Lumpur, 2012, (International)
  • Certificate of Excellent Service, University Malaya, 2011, (University)
  • Finalis Anugerah Perdana Menteri Penggiat Sosial Wanita 2011, Menteri Pembangunan Wanita, Keluarga Dan Masyarakat, 2011, (National)
  • 50 Emerging Women Leader in Asia Pacific 2011 Advance Australia, Australian Government, 2011, (International)
  • Pingat Bakti Setia Jabatan Penjara Malaysia, Jabatan Penjara Malaysia, 2009, (National)
  • Excellence Service Award, University Malaya, 2008, (University)
  • Merdeka Award, Exxon Mobil, Petronas and Shell, 2008, (National)
  • Tun Mahathir Science Award, Malaysian Academy of Science, 2008, (National)
  • Certificate of Excellent Service, University Malaya, 2007, (University)
  • Certificate of Excellent Service, University Malaya, 2006, (University)
  • Excellence Service Award, University Malaya, 2005, (University)
  • Swarovski Life Ball Crystal of Hope Award, Austrian Life Ball, 2005, (International)
  • Australian-Asian Fellowship Award, Australian Government, 2002, (International)
  • International Aids Fellowship Programme, International Society of Infectious Diseases, 1999, (International)
  • Fellow in Infectious Diseases, Senior Medical Staff, Fairfield Hospital, 1995, (International)

PRESENTATIONS
(Title), (Event), (Date Presented), (Organiser), (Level).


PLEANARY/KEYNOTE SPEAKER
  • Substance Abuse and Harm Reduction, XVII International AIDS Conference August 2008. Mexico City., 2008-08-01 to  , (International)
INVITED SEMINAR
  • , The First ASEANS Deans' Summit : Connecting ASEAN Medical Schools towards One Community" - International Conference in Medicine and Public Health (ICMPH) 2012, 2012-09-17 to 2012-09-17, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand, (International)
  • , Seminar on Rights and Responsibilities of Government Doctors, 2012-11-03 to 2012-11-03, SCHOMOS / MOH, (National)
INVITED SPEAKER
  • Carbapenem-resistant Pseudomonas and Acinetobacter, 13th International Congress in Infectious Diseases (ICID). Kuala Lumpur, 2008-06-23 to  , International Society of Infectious Diseases, (International)
  • Monash University Malaysia Graduation Address, Monash University Malaysia Graduation Address, 2010-04-10 to 2010-04-10, Monash University , (International)
  • HIV Prevention in Malaysia, Global Health Centre, Columbia University, Almaty, Kazakshtan. May 2010. HIV Prevention in Malaysia, 2010-05-31 to 2010-05-31, Columbia University, (International)
  • , 5th National Conference for Clinical Research 2011, 2011-06-22 to 2011-06-24, Ministry of Health Malaysia, (National)
  • HIV and AIDS in Muslim Countries, Women In Science and Technology in Muslim Countries , 2011-09-21 to  , MOSTI, (National)
  • HIV care under universal coverage:challenges and choices, Global Public Health International Symposium on "Universal Coverage", 2011-10-03 to 2011-10-01, Monash University, (International)
  • HIV and Mobility, Asia Pacific Conference in Medical Virology 2012 , 2012-06-06 to 2012-06-08, APCMV 2012 Congress, (International)
  • AIDS in Asia at the symposia on HIV , 13th Asia-Pacific Congress of Clinical Microbiology and Infection (13th APCCMI, formerly WPCCID) , 2012-10-25 to 2012-10-28, 13th Asia-Pacific Congress of Clinical Microbiology and Infection (13th APCCMI, formerly WPCCID) , (International)
  • Viral Hepatitis and HIV Coinfection, Singapore AIDS COnference, 2012-11-17 to 2012-11-17, Singapore AIDS Conference, (International)
  • International Collaboration & Getting to Zero, 26th Annual Japan HIV Conference , 2012-11-24 to 2012-11-26, Japanese Society for AIDS Research, (International)
  • Accreditation on Medical School, Summit on Medical Education 2013, 2013-08-23 to 2013-08-23, University Teknologi MARA, (National)
  • , 7th National Infectious Diseases Seminar and Workshop (NIDSAW)2012, 2013-11-06 to 2013-11-06, Universiti Putra Malaysia, (National)
  • Towards A Unified Approach to Patient Safety : The ASEAN Perspective, 1st ASEAN Patient Safety Congress, 2015-06-25 to 2015-06-26, UP College of Medicine
  • Malaysian Society for Molecular Biology and Biotechnology, 22nd Annual MSMBB Scientific Meeting, 2015-09-08 to 2015-09-09, Malaysian Society for Molecular Biology and Biotechnology, (National)
  • Population Approach to HIV Prevention & Control, The 5th AHLA International Health Literacy Conference, 2017-11-12 to 2017-11-14, Centre for Population Health (CePH), Dept of Social and Preventive Medicine, Faculty of Medicine, UM, (National)
PRESENTER
  • , Islam and HIV/AIDS International Conference 2012, 2013-11-19 to 2013-11-21, Department of Islamic Development Malaysia, (National)
  • Two decades of harm reduction in Malaysia, The 27th IFNGO World Conference, 2017-11-06 to 2017-11-08, IFNGO - International Federation of Non - Government Organizations for the Prevention of Drug and Substance Abuse, (International)
OTHERS
  • International Experience of Harm Reduction, Xth International Conference of Drug Dependence. Xian, China. October 2008, 2008-10-01 to  , The Chinese Society of Addiction Medicine , (International)
  • Scalling up Harm Reduction in Malaysia, XIII th International Congress of AIDS in Asia and the Pacific (ICAAP)Aug 2009, 2009-08-01 to  , AIDS Soceity Asia Pacific, (International)
  • Substance Abuse and Harm Reduction in Malaysia, XV111 International AIDS Conference July 2010. Vienna. Substance Abuse and Harm Reduction in Malaysia, 2010-07-17 to 2010-07-24, International AIDS Society, (International)
  • Respondent Driven Sampling Involving the Community, XV111 International AIDS Conference July 2010. Vienna. Respondent Driven Sampling Involving the Community, 2010-07-17 to 2010-07-24, International AIDS Society, (International)
  • , MMA SECOND SEMINAR ON POSTGRADUATE MEDICAL EDUCATION, 2013-01-26 to 2013-01-26, Malaysian Medical Association, (National)

EXPERT LINKAGES
(Linkages Description), (Organisation), (Year of Involvement), (Duration), (Level).


  • Scientific Exchange Program, Global Health Equity Scholars - Yale university , 2016, (International)
  • PhD Selection Committee Pasteur-Paris Institute, Pasteur Institute, Paris , 2014, 1, (International)
  • Student Exchange Program, Yale university , 2013, 3, (International)
  • Co-chairperson, Scientific Program Committee International AIDS Conference, Vienna 2010, International AIDS Society , 2010, 24, (International)
  • Member, Oversight Committee for the Second Independent Evaluation of UNAIDS, UNAIDS, 2008, 24, (International)
  • Executive Committee Member, International Society for Infectious Diseases (ISID), 2008, (International)
  • Member, United Nations Reference Group on HIV and Injecting Drug Use, United Nations , 2007, 24, (International)
  • Advisory Board Member, UNAIDS Interagency Reference Group for the Technical Support Facility in Southeast Asia and the Pacific, UNAIDS, 2006, 24, (International)
  • Member, United Nations Regional Task Force on HIV Prevention in Injecting Drug Users, United Nations, 2006, 24, (International)
  • Advisory Board Member, International Harm Reduction Development, International Harm Reduction Development, 2006, 24, (International)
  • Vice-Chair, Global Initiatives Committee- Foundation for AIDS Research (amfAR), amfAR, 2006, 24, (International)
  • Executive Committee Member, International Harm Reduction Association, International Harm Reduction Association, 2006, 24, (International)
  • Steering Committee Member, Asian Network on Surveillance of Resistant Pathogens (ANSORP), ANSORP, 2005, 24, (International)
  • Steering Committee Member. TREAT Asia. Regional Cooperative Network on Research and Therapeutics in HIV/AIDS. American Foundation for AIDS Research (amfAR), amfAR, 2005, 24, (International)
  • Member, Technical Expert Panel - UNAIDS Regional Task Force on IDU, consultative meeting, UNAIDS, 2005, (International)
  • Member, Expert Panel - National Consensus Guidelines for the Management of Extended-spectrum Beta-Lactamase Producing Bacteria, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, 2001, (National)
  • Co-Chairperson - Consensus meeting on the use of antiretroviral therapy in Malaysia, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, 2001, (National)
  • Chairperson - Consensus Guidelines on the management of Staphylococcus aureus infections, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, 1999, (National)
  • Member, Expert Panel - Consensus on the use of antiretroviral therapy in emerging nations, BMS, 1998, (International)

EXPERT/TECHNICAL CONTRIBUTIONS
(Activity), (Organisation), (Role), (From)-(Until), (Level).


  • Member, National Health Advisory Committee, Ministry of Health Malaysia, Committee Member, 2018-2020, (National)
  • Board of Director, Clinical Research Malaysia, Advisor, 2017-2019, (National)
  • Board Member, UMMC, Advisor, 2011-2020, (University)
  • Board Member, UMSC, Advisor, 2011-2020, (University)
  • Country Coordinating Mechanism , The Malaysian Global Fund, Country Coordinating Mechanism , The Malaysian Global Fund, Vice Chair / Member, 2009-Present, (National)
  • Chairman, Malaysian AIDS Foundation, Chairman, 2006-2020, (National)
  • Board Member, Malaysian AIDS Council, Expert Advisor, 2006-2020, (National)

CONTRIBUTION TO SOCIETY
(Contribution To Society), (Level), (Start Date), (End Date).


  • Malaysian AIDS Foundation Board of Trustees, (National), 14/05/2018 until 13/05/2020
  • Speciality Subcommittee Infectious Disease - Committee Member, (National), 04/01/2016 until 03/01/2018
  • Angggota Majlis Penasihat Program Jelajah Kaseh Orang Muda OKB derma Organ Demi Kehidupan, (National), 24/07/2015 until  
  • Perlantikan sebagai External Reviewer bagi garis panduan Antibiotik Kebangsaan 2014, (National), 17/12/2014 until  
  • 20th International AIDS Conference Melbourne, Australia - Editors Reviewers, (International), 20/07/2014 until 25/07/2014
  • Ahli Majlis Perubatan Malaysia, (National), 22/12/2013 until 21/12/2016
  • Ahli Panel Pakar Bidang Perubatan Dan Sains Kesihatan, (National), 19/02/2013 until 18/02/2015
  • Subspeciality Training Subcommittee, (Government), 28/09/2012 until 27/09/2014
  • National Specialist Register, (National), 20/06/2012 until  
  • Panel Penilai Pakar untuk Penilaian Permohonan Pembiayaan dan Pemantauan Dana R, D&C Kementerian Sains, teknologi dan Inovasi (MOSTI), (National), 01/03/2012 until 31/12/2015
  • Executive Committee, Malaysian AIDS Council, (National), 01/01/2010 until 31/12/2016
  • Vice-Chair, Country Coordinating Mechanism, The Malaysian Global Fund Initiative ., (National), 01/01/2009 until 31/07/2009
  • Member, National Health Promotions Board, (National), 01/01/2008 until 01/04/2010
  • Malaysian AIDS Foundation - Chairman, (National), 01/01/2006 until 31/12/2016
  • President Malaysian AIDS Council, (National), 01/01/2006 until 01/04/2010
  • Member, National Task Force on Harm Reduction, Ministry of Health Malaysia, (National), 01/01/2005 until  
  • Member, National Infection Control and Antibiotic Committee, Ministry of Health, (National), 01/01/2005 until  
  • Convenor, Malaysian Harm Reduction Working Group, (National), 01/01/2004 until  

SUPERVISION


POST GRADUATE STUDENT
(Name of Degree), (Name of Candidates), (Title of Thesis), (Academic Session)

Completed
  • Doctoral Degree (phd), Tee Kok Keng, PhD, 2008/2009
  • Master Degree, Dr Sufian Adnan, MMed, 2008/2009
  • Master Degree, Dr Leong Chee Loong, ADVANCED TRAINING IN INFECTIOUS DISEASES, 2008/2009
  • Master Degree, Dr James Koh, ADVANCED TRAINING IN INFECTIOUS DISEASES, 2008/2009
  • Master Degree, Dr Sufian Adnan, MMed, 2007/2008
  • Master Degree, Dr Sufian Adnan, MMed, 2006/2007
  • Master Degree, Dr Wong Chew Ming, MMed, 2004/2005
  • Master Degree, Dr Muhammad Zainafyah Bin Zakaria, MMed, 2004/2005

Ongoing
  • Doctoral Degree (phd), Tan Hong Yien, PhD, 2009/2010
  • Master Degree, Martin Choo, MSC, 2009/2010
  • Doctoral Degree (phd), Yong Yean Kong, PhD, 2009/2010
  • Master Degree, Tunku Noor Hayati Binti Tunku Abdul Rahman, MSC, 2009/2010
  • Doctoral Degree (phd), Dr Salwa Mudddthir Ismail Norien, PhD, 2009/2010
  • Master Degree, Dr Azureen Azmel, MMed, 2008/2009